Register Login
Register to leave comments
  • News bot Sept. 3, 2026, 12:48 p.m.

    📋 ABBVIE INC. (ABBV) - Clinical Trial Update

    Filing Date: 2026-09-03

    Accepted: 2026-09-03 08:47:46

    Event Type: Clinical Trial Update

    Event Details:

    ABBVIE INC. (ABBV) Announces Clinical Trial Update ABBVIE INC. (ABBV) provided an update on its clinical development programs. Clinical Development Highlights:
    • Collaboration: Apogee Therapeutics, Inc.
      • targeting multiple validated inflammatory pathways in large immunology and inflammation markets, including atopic dermatitis (AD), asthma, and chronic obstructive pulmonary disease (COPD). AbbVie Inc. +1 (847) 938-9190
      • targeting multiple validated inflammatory pathways. APG273 combines zumilokibart with APG333, an antibody that blocks thymic stromal lymphopoietin (TSLP), a signaling protein that acts as an early trigger of inflammation in the lungs. Phase 1 data showed that APG333 has a long half-life and was able to suppress relevant type 2 inflammatory markers for up to six months after dosing. The Phase 1 data with APG333 and positive interim results from a Phase 1b study of zumilokibart in asthma, support the potential of the APG273 combination with quarterly or twice-yearly injections in asthma. For additional background on the acquisition, please read the announcement press release here and view AbbVie's investor presentation here. Financial Terms AbbVie has acquired all outstanding Apogee common stock for $135.11 per share in cash, for a total equity value of approximately $10.9 billion. Apogee's common stock ceased trading on the NASDAQ stock exchange prior to market open on Sept. 3, 2026
      • targeting dermatologic, respiratory and other inflammatory and immunological diseases –Apogee's lead asset, zumilokibart, is a late-stage, half-life extended monoclonal antibody targeting IL-13, in development for patients with atopic dermatitis –Apogee's pipeline also includes APG273, a potential best-in-category long-acting combination targeting IL-13 and thymic stromal lymphopoietin (TSLP), in development for asthma –AbbVie reaffirms previously issued 2026

    🔬 Clinical Development Pipeline (ABBVIE INC.):

    Product Type Development Stage Therapeutic Area Source
    XEN63 Glaucoma Treatment System Drug Phase PHASE3 Primary Open Angle Glaucoma ClinicalTrials.gov
    Placebo-Matching Atogepant Other Phase PHASE3 Episodic Migraine ClinicalTrials.gov
    Atogepant Other Phase PHASE3 Episodic Migraine ClinicalTrials.gov
    Placebo Other Phase PHASE2 Obesity ClinicalTrials.gov
    ABBV-295 Other Phase PHASE2 Obesity ClinicalTrials.gov
    Placebo for Atogepant Other Phase PHASE3 Chronic Migraine ClinicalTrials.gov
    VOLITE XC Other Phase PHASE3 Neck Lines ClinicalTrials.gov
    Placebo for ABBV-142 Other Phase PHASE2 Idiopathic Pulmonary Fibrosis ClinicalTrials.gov
    ABBV-142 Other Phase PHASE2 Idiopathic Pulmonary Fibrosis ClinicalTrials.gov
    ABBV-701 Other Phase PHASE2 Crohn's Disease ClinicalTrials.gov
    Trosunilimab Other Phase PHASE2 Crohn's Disease ClinicalTrials.gov
    Risankizumab Other Phase PHASE2 Crohn's Disease ClinicalTrials.gov
    Matching Placebo for PVEK Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Azacitidine Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Venetoclax Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Pivekimab Sunirine Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Artificial Tears Other Phase PHASE2 Diabetic Retinopathy ClinicalTrials.gov
    Topical Steroid Other Phase PHASE2 Diabetic Retinopathy ClinicalTrials.gov
    Sham Other Phase PHASE2 Diabetic Retinopathy ClinicalTrials.gov
    Surabgene Lomparvovec Other Phase PHASE2 Diabetic Retinopathy ClinicalTrials.gov
    Cisplatin Other Phase PHASE1 Non Small Cell Lung Carcinoma ClinicalTrials.gov
    Pemetrexed Other Phase PHASE1 Non Small Cell Lung Carcinoma ClinicalTrials.gov
    Carboplatin Other Phase PHASE1 Non Small Cell Lung Carcinoma ClinicalTrials.gov
    Pembrolizumab Other Phase PHASE1 Non Small Cell Lung Carcinoma ClinicalTrials.gov
    Budigalimab Other Phase PHASE1 Non Small Cell Lung Carcinoma ClinicalTrials.gov
    Telisotuzumab Adizutecan Other Phase PHASE1 Non Small Cell Lung Carcinoma ClinicalTrials.gov
    Nab-paclitaxel Other Phase PHASE1 Cancer ClinicalTrials.gov
    ABBV-181 Other Phase PHASE1 Cancer ClinicalTrials.gov
    ABBV-368 Other Phase PHASE1 Cancer ClinicalTrials.gov
    ABBV-927 Other Phase PHASE1 Cancer ClinicalTrials.gov
    Panitumumab Other Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov
    Bevacizumab Other Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov
    Leucovorin Other Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov
    Oxaliplatin Other Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov
    Fluorouracil Other Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov
    Telisotuzumab Vedotin Other Phase PHASE2 Non-Small Cell Lung Cancer ClinicalTrials.gov
    Lutikizumab Other Phase PHASE3 Hidradenitis Suppurativa ClinicalTrials.gov
    Amrubicin Other Phase PHASE3 Small Cell Lung Cancer ClinicalTrials.gov
    Lurbinectedin Other Phase PHASE3 Small Cell Lung Cancer ClinicalTrials.gov
    Topotecan Other Phase PHASE3 Small Cell Lung Cancer ClinicalTrials.gov
    ABBV-706 Other Phase PHASE3 Small Cell Lung Cancer ClinicalTrials.gov
    Venetoclax Oral Tablet Other Phase PHASE1 Relapsed Adult AML ClinicalTrials.gov
    Etentamig Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Pomalidomide Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Dexamethasone Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Daratumumab Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Surzetoclax Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Placebo-Matching Ubrogepant Other Phase PHASE3 Migraine ClinicalTrials.gov
    Ubrogepant Other Phase PHASE3 Migraine ClinicalTrials.gov
    Irinotecan Other Phase PHASE2 Metastatic Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    Folinic acid/ Leucovorina Other Phase PHASE2 Metastatic Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    Livmoniplimab Other Phase PHASE2 Non-Small Cell Lung Cancer ClinicalTrials.gov
    Adalimumab Other Phase PHASE3 Juvenile Psoriatic Arthritis ClinicalTrials.gov
    Mirvetuximab Soravtansine Other Phase PHASE2 Epithelial Ovarian Cancer ClinicalTrials.gov
    Bretisilocin Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Breath Test Other Preclinical IBD ClinicalTrials.gov
    VOLUX Other Phase PHASE4 Jawline and Neck Appearance ClinicalTrials.gov
    VOLUMA Other Phase PHASE4 Jawline and Neck Appearance ClinicalTrials.gov
    SKINVIVE Other Phase PHASE4 Jawline and Neck Appearance ClinicalTrials.gov
    OnabotulinumtoxinA Other Phase PHASE4 Jawline and Neck Appearance ClinicalTrials.gov
    Levonorgestrel/Ethinyl Estradiol Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    JUVÉDERM VOLIFT with Lidocaine Other Phase PHASE3 Nasolabial Folds ClinicalTrials.gov
    NOA LIFT Other Phase PHASE3 Nasolabial Folds ClinicalTrials.gov
    Zanubrutinib Other Phase PHASE2 Chronic Lymphocytic Leukemia ClinicalTrials.gov
    Magnetic Resonance Imaging Other Phase PHASE2 Chronic Lymphocytic Leukemia ClinicalTrials.gov
    Computed Tomography Other Phase PHASE2 Chronic Lymphocytic Leukemia ClinicalTrials.gov
    Bone Marrow Biopsy Other Phase PHASE2 Chronic Lymphocytic Leukemia ClinicalTrials.gov
    Bone Marrow Aspiration Other Phase PHASE2 Chronic Lymphocytic Leukemia ClinicalTrials.gov
    Biospecimen Collection Other Phase PHASE2 Chronic Lymphocytic Leukemia ClinicalTrials.gov
    Cyclophosphamide Other Phase PHASE3 Amyloid Light Chain (AL) Amyloidosis ClinicalTrials.gov
    Bortezomib Other Phase PHASE3 Amyloid Light Chain (AL) Amyloidosis ClinicalTrials.gov
    Itraconazole Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    ABBV-722 Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    ABBV-319 Other Phase PHASE1 Diffuse Large B-Cell Lymphoma ClinicalTrials.gov
    Ibrutinib Other Phase PHASE2 Mantle Cell Lymphoma (MCL) ClinicalTrials.gov
    standard of care chemotherapy plus gemtuzumab ozogamicin Drug Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Venetoclax plus Azacitidine Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Selinexor Other Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Elotuzumab Other Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Carfilzomib Other Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Etoposide Other Phase PHASE2 Small Cell Lung Cancer ClinicalTrials.gov
    Atezolizumab Other Phase PHASE2 Small Cell Lung Cancer ClinicalTrials.gov
    Placebo for AGN-151607-DP Other Phase PHASE2 Ventral Hernia ClinicalTrials.gov
    AGN-151607-DP Other Phase PHASE2 Ventral Hernia ClinicalTrials.gov
    Upadacitinib Other Phase PHASE3 Severe Alopecia Areata ClinicalTrials.gov
    BOTOX Other Phase PHASE3 Masseter Muscle Prominence ClinicalTrials.gov
    Positron Emission Tomography Other Phase PHASE1 Recurrent Diffuse Large B-Cell Lymphoma ClinicalTrials.gov
    Epcoritamab Other Phase PHASE1 Recurrent Diffuse Large B-Cell Lymphoma ClinicalTrials.gov
    Placebo for ABBV-1758 Other Phase PHASE1 Alzheimer's Disease ClinicalTrials.gov
    ABBV-1758 Other Phase PHASE1 Alzheimer's Disease ClinicalTrials.gov
    Itraconazole (ITZ) Other Phase PHASE1 Hepatocellular Carcinoma ClinicalTrials.gov
    ABBV-400 Other Phase PHASE1 Hepatocellular Carcinoma ClinicalTrials.gov
    Gemtuzumab Ozogamicin Other Phase PHASE3 Acute Myeloid Leukemia ClinicalTrials.gov
    Cytarabine Other Phase PHASE3 Acute Myeloid Leukemia ClinicalTrials.gov
    Fludarabine Other Phase PHASE3 Acute Myeloid Leukemia ClinicalTrials.gov
    Brimonidine tartrate ophthalmic solution eye drops Other Phase PHASE2 Recurrent Ovarian Cancer ClinicalTrials.gov
    Prednisolone acetate ophthalmic suspension 1% eye drops Other Phase PHASE2 Recurrent Ovarian Cancer ClinicalTrials.gov
    Lubricating Eye Drops Other Phase PHASE2 Recurrent Ovarian Cancer ClinicalTrials.gov
    Emraclidine 30 mg Other Phase PHASE2 Schizophrenia ClinicalTrials.gov
    Aqueous PGE2 and inflammatory cytokines measurements Other Phase PHASE1 Diabetic Retinopathy ClinicalTrials.gov
    Placebo - Preservative-free artificial tears Other Phase PHASE1 Diabetic Retinopathy ClinicalTrials.gov
    Ketorolac 0.45% ophthalmic solution Other Phase PHASE1 Diabetic Retinopathy ClinicalTrials.gov
    AGN-151586 Other Phase PHASE2 Forehead Lines ClinicalTrials.gov
    Upadacitinib Matching Placebo Other Phase PHASE2 EoE ClinicalTrials.gov
    Upadacitinib 30mg Dose Other Phase PHASE2 EoE ClinicalTrials.gov
    Sitagliptin Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Pitavastatin Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Digoxin Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Metformin Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Midazolam Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Aflibercept Other Phase PHASE2 Diabetic Retinopathy (DR) ClinicalTrials.gov
    ABBV-RGX-314 Dose 4 Other Phase PHASE2 Diabetic Retinopathy (DR) ClinicalTrials.gov
    ABBV-RGX-314 Dose 3 Other Phase PHASE2 Diabetic Retinopathy (DR) ClinicalTrials.gov
    ABBV-RGX-314 Dose 2 Other Phase PHASE2 Diabetic Retinopathy (DR) ClinicalTrials.gov
    ABBV-RGX-314 Dose 1 Other Phase PHASE2 Diabetic Retinopathy (DR) ClinicalTrials.gov
    ABBV-711 Other Phase PHASE1 Advanced Squamous Tumors ClinicalTrials.gov
    Gemcitabine Other Phase PHASE2 Pancreatobiliary Cancers ClinicalTrials.gov
    ELAPR002f Injectable Gel Other Phase PHASE3 Atrophic Acne Scars ClinicalTrials.gov
    Saline Active Control Other Phase PHASE3 Atrophic Acne Scars ClinicalTrials.gov
    Ranibizumab Control Other Phase PHASE3 Neovascular Age-related Macular Degeneration ClinicalTrials.gov
    Surabgene Lomparvovec (ABBV-RGX-314) Other Phase PHASE3 Neovascular Age-related Macular Degeneration ClinicalTrials.gov
    ABBV-438 Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Emraclidine Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Placebo for Icalcaprant Other Phase PHASE2 Bipolar I Disorder ClinicalTrials.gov
    Icalcaprant Other Phase PHASE2 Bipolar I Disorder ClinicalTrials.gov
    Placebo for ABBV-295 Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Placebo for Ubrogepant Other Phase PHASE3 Migraine ClinicalTrials.gov
    Glecaprevir/pibrentasvir Other Phase PHASE1 Hepatitis C ClinicalTrials.gov
    ABBV-291 Other Phase PHASE1 Non-Hodgkin's Lymphoma ClinicalTrials.gov
    Risankizumab SC Other Phase PHASE3 Crohn's Disease ClinicalTrials.gov
    Risankizumab On-Body Injector (OBI) Other Phase PHASE3 Crohn's Disease ClinicalTrials.gov
    Placebo for Risankizumab IV Other Phase PHASE3 Crohn's Disease ClinicalTrials.gov
    Risankizumab IV Other Phase PHASE3 Crohn's Disease ClinicalTrials.gov
    Placebo for Risankizumab SC Other Phase PHASE3 Crohn's Disease ClinicalTrials.gov
    Lenalidomide Other Phase PHASE1 Relapsed/Refractory Multiple Myeloma ClinicalTrials.gov
    Adalimumab Matching Placebo Other Phase PHASE3 Rheumatoid Arthritis ClinicalTrials.gov
    Tocilizumab Other Phase PHASE3 Juvenile Idiopathic Arthritis ClinicalTrials.gov
    ABT-494 Other Phase PHASE2 Crohn's Disease (CD) ClinicalTrials.gov
    Nab- Paclitaxel Other Phase PHASE3 Non-Small Cell Lung Cancer ClinicalTrials.gov
    Paclitaxel Other Phase PHASE3 Non-Small Cell Lung Cancer ClinicalTrials.gov
    ABBV-1480 Other Phase PHASE3 Non-Small Cell Lung Cancer ClinicalTrials.gov
    JUVÉDERM ULTRA PLUS XC Other Phase PHASE4 Mid Face Volume Deficit ClinicalTrials.gov
    JUVÉDERM ULTRA XC Other Phase PHASE4 Mid Face Volume Deficit ClinicalTrials.gov
    SKINVIVE by JUVÉDERM Other Phase PHASE4 Mid Face Volume Deficit ClinicalTrials.gov
    JUVÉDERM VOLLURE XC Other Phase PHASE4 Mid Face Volume Deficit ClinicalTrials.gov
    JUVÉDERM VOLBELLA XC Other Phase PHASE4 Mid Face Volume Deficit ClinicalTrials.gov
    JUVÉDERM VOLUMA XC Other Phase PHASE4 Mid Face Volume Deficit ClinicalTrials.gov
    JUVÉDERM VOLUX XC Other Phase PHASE4 Mid Face Volume Deficit ClinicalTrials.gov
    Thioguanine Other Phase PHASE2 T-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Methotrexate Other Phase PHASE2 T-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Nelarabine Other Phase PHASE2 T-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Mercaptopurine Other Phase PHASE2 T-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Intrathecal triple therapy (methotrexate + hydrocortisone + cytarabine) Drug Phase PHASE2 T-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Dasatinib Other Phase PHASE2 T-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Calaspargase pegol Other Phase PHASE2 T-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Daunorubicin Other Phase PHASE2 T-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Vincristine Other Phase PHASE2 T-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Botulinum toxin Other Preclinical Hidradenitis Suppurativa ClinicalTrials.gov
    ABBV-932 Other Phase PHASE1 Bipolar Disorder ClinicalTrials.gov
    ABBV-101 Other Phase PHASE1 Hematologic Cancer ClinicalTrials.gov
    Dupilumab Other Phase PHASE3 Atopic Dermatitis ClinicalTrials.gov
    ARTIA Reconstructive Tissue Matrix Other Phase PHASE3 Breast Reconstruction ClinicalTrials.gov
    Standard of Care Other Phase PHASE2 Diabetic Retinopathy, DR ClinicalTrials.gov
    Ranibizumab Other Phase PHASE2 Neovascular Age-Related Macular Degeneration (nAMD) ClinicalTrials.gov
    Vedolizumab Other Phase PHASE3 Ulcerative Colitis ClinicalTrials.gov
    Placebo for ABBV-859 Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    ABBV-859 Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Aflibercept (EYLEA®) Other Phase PHASE3 AMD ClinicalTrials.gov
    Hypofractionated WPRT Other Phase PHASE2 Prostate Cancer ClinicalTrials.gov
    Conventionally-fractionated WPRT Other Phase PHASE2 Prostate Cancer ClinicalTrials.gov
    Ibrutinib Oral Tablet Other Phase PHASE2 Chronic Lymphocytic Leukemia ClinicalTrials.gov
    Loncastuximab Tesirine and Epcoritamab Other Phase PHASE2 Aggressive Diffuse Large B-cell Lymphoma ClinicalTrials.gov
    onabotulinum toxin A Other Phase PHASE2 Neuropathic Pain ClinicalTrials.gov
    Ethinyl Estradiol + Levonorgestrel Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Upadacitinib Placebo Other Phase PHASE3 Alopecia Areata ClinicalTrials.gov
    Topiramate 100 mg Other Phase PHASE4 Migraine ClinicalTrials.gov
    Propranolol 160 mg Other Phase PHASE4 Migraine ClinicalTrials.gov
    Atogepant 60 mg Other Phase PHASE4 Migraine ClinicalTrials.gov
    Dexamethasone implant Other Phase PHASE4 Diabetic Macular Edema ClinicalTrials.gov
    Trifluridine/Tipiracil Other Phase PHASE3 Colorectal Cancer ClinicalTrials.gov
    Multigated Acquisition Scan Other Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Idarubicin Other Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Granulocyte Colony-Stimulating Factor Other Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Echocardiography Other Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Virtual Reality Other Approved Irritable Bowel Syndrome With Constipation ClinicalTrials.gov
    MRE Other Approved Crohn Disease ClinicalTrials.gov
    Gilteritinib Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Mitoxantrone Hydrochloride Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Idarubicin Hydrochloride Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Daunorubicin Hydrochloride Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Fludarabine Phosphate Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Docetaxel Other Phase PHASE3 Non Small Cell Lung Cancer ClinicalTrials.gov
    Cariprazine Other Phase PHASE3 Depression ClinicalTrials.gov
    Teclistamab Other Phase PHASE3 Relapsed or Refractory Multiple Myeloma ClinicalTrials.gov
    ABBV-313 Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    ABBV-547 Placebo Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    ABBV-547 Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Nacresertib Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    ABBV-2001 Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Iberdomide Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Mezigdomide Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    ABBV-8736 Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Placebo for Nacresertib Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    ABBV-901 Other Phase PHASE1 Ovarian Cancer ClinicalTrials.gov
    Bimatoprost SR Other Phase PHASE3 Open-Angle Glaucoma ClinicalTrials.gov
    Ravagalimab Other Phase PHASE2 Rheumatoid Arthritis ClinicalTrials.gov
    Osimertinib Other Phase PHASE2 Non-Small Cell Lung Cancer ClinicalTrials.gov
    ABBV-277 Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    ABBV-453 Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Placebo for BOTOX Other Phase PHASE3 Masseter Muscle Prominence ClinicalTrials.gov
    Dupilumab 300mg Dose Other Phase PHASE3 Atopic Dermatitis ClinicalTrials.gov
    Upadacitinib 15mg Dose Other Phase PHASE3 Atopic Dermatitis ClinicalTrials.gov
    Ruxolitinib Other Phase PHASE1 Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome ClinicalTrials.gov
    Questionnaire Administration Other Phase PHASE1 Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome ClinicalTrials.gov
    Punch Biopsy Other Phase PHASE1 Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome ClinicalTrials.gov
    Echocardiography Test Other Phase PHASE1 Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome ClinicalTrials.gov
    Etentamig (ABBV-383) Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Rituximab Other Phase PHASE2 Marginal Zone Lymphoma ClinicalTrials.gov
    Placebo for Topiramate Other Phase PHASE3 Migraine ClinicalTrials.gov
    Topiramate Other Phase PHASE3 Migraine ClinicalTrials.gov
    CoolSculpting Elite System Other Phase PHASE4 Non-Surgical Fat Reduction ClinicalTrials.gov
    Tagraxofusp Other Phase PHASE2 Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) ClinicalTrials.gov
    ABBV-519 Other Phase PHASE1 Systemic Lupus Erythematosus ClinicalTrials.gov
    OnabotulinumtoxinA 145 UNT [Botox] Other Phase PHASE4 Drug-resistant Focal Seizure ClinicalTrials.gov
    IMGN853 Other Phase PHASE2 Endometrial Cancer ClinicalTrials.gov
    Azirkitug Other Phase PHASE1 Non-Small Cell Lung Cancer ClinicalTrials.gov
    VOLUMA XC Other Phase PHASE3 Mid Face Volume Deficit ClinicalTrials.gov
    NOA VOLUME Other Phase PHASE3 Mid Face Volume Deficit ClinicalTrials.gov
    Antidepressant Therapy (ADT) Drug Phase PHASE2 Generalized Anxiety Disorder (GAD) ClinicalTrials.gov
    Placebo for ABBV-932 Other Phase PHASE2 Generalized Anxiety Disorder (GAD) ClinicalTrials.gov
    Placebo for Upadacitinib Other Phase PHASE3 Atopic Dermatitis ClinicalTrials.gov
    Pirtobrutinib Other Phase PHASE2 Waldenstrom Macroglobulinemia ClinicalTrials.gov
    REFRESH OPTIVE UD Other Phase PHASE3 Dry Eye Disease ClinicalTrials.gov
    ABBV-444 Other Phase PHASE3 Dry Eye Disease ClinicalTrials.gov
    ABBV-969 Other Phase PHASE1 Metastatic Castration-Resistant Prostate Cancer ClinicalTrials.gov
    NX-13 Placebo Other Phase PHASE2 Ulcerative Colitis ClinicalTrials.gov
    NX-13 750mg Other Phase PHASE2 Ulcerative Colitis ClinicalTrials.gov
    NX-13 250mg Other Phase PHASE2 Ulcerative Colitis ClinicalTrials.gov
    Paricalcitol Other Phase PHASE3 Chronic Kidney Disease (CKD) ClinicalTrials.gov
    SYFOVRE Other Phase PHASE1 Geographic Atrophy ClinicalTrials.gov
    ABBV-6628 Other Phase PHASE1 Geographic Atrophy ClinicalTrials.gov
    Combined Oral Contraceptive Other Phase PHASE3 Endometriosis ClinicalTrials.gov
    Elagolix Other Phase PHASE3 Endometriosis ClinicalTrials.gov
    Screener Other Approved Stroke ClinicalTrials.gov
    Pancrelipase Capsules Other Phase PHASE4 Exocrine Pancreatic Insufficiency ClinicalTrials.gov
    Venetoclax Oral Tablet [Venclexta] Other Phase PHASE2 Mantle Cell Lymphoma ClinicalTrials.gov
    NB-UVB (narrow-band ultraviolet B) Phototherapy Drug Phase PHASE3 Vitiligo ClinicalTrials.gov
    Osimertinib (Osi) Other Phase PHASE2 Non-Squamous Non-Small Cell Lung Cancer ClinicalTrials.gov
    Cofetuzumab Pelidotin Other Phase PHASE1 Cancer ClinicalTrials.gov
    Olaparib Other Phase PHASE2 Ovary Cancer ClinicalTrials.gov
    Mirvetuximab Soravtansine-gynx Other Phase PHASE2 Ovary Cancer ClinicalTrials.gov
    Best Supportive Care (BSC) Other Phase PHASE3 Acute Myeloid Leukemia (AML) ClinicalTrials.gov
    Mirvetuximab soravtansine plus Bevacizumab Other Phase PHASE3 Ovarian Cancer ClinicalTrials.gov
    IMGN151 Other Phase PHASE2 Gynecologic Cancers ClinicalTrials.gov
    HArmonyCa Lidocaine Injectable Gel Other Phase PHASE3 Mid Face Volume Deficit ClinicalTrials.gov
    Standard Chemotherapy Drug Phase PHASE1 Leukemia ClinicalTrials.gov
    ABBV-951 Other Phase PHASE3 Parkinson's Disease (PD) ClinicalTrials.gov
    ABBV-1451 Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Punch biopsies of the skin at week 28 visit Other Phase PHASE4 Psoriasis ClinicalTrials.gov
    Punch biopsies of the skin at baseline visit Other Phase PHASE4 Psoriasis ClinicalTrials.gov
    Risankizumab-Rzaa Other Phase PHASE4 Psoriasis ClinicalTrials.gov
    KYBELLA Other Phase PHASE4 Facial Contouring ClinicalTrials.gov
    SkinMedica Products Other Phase PHASE4 Facial Contouring ClinicalTrials.gov
    JUVÉDERM Other Phase PHASE4 Facial Contouring ClinicalTrials.gov
    Lumigan Vehicle Other Phase PHASE1 Open-angle Glaucoma ClinicalTrials.gov
    Sham Administration Other Phase PHASE1 Open-angle Glaucoma ClinicalTrials.gov
    AGN-193408 SR Other Phase PHASE1 Open-angle Glaucoma ClinicalTrials.gov
    Lumigan Other Phase PHASE1 Open-angle Glaucoma ClinicalTrials.gov
    Elezanumab Other Preclinical Acute Spinal Cord Injury (SCI) ClinicalTrials.gov
    Placebo for Nascertib Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Nascertib Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Bortezomib + Lenalidomide + Dexamethasone Other Phase PHASE1 Myeloma Multiple ClinicalTrials.gov
    Isatuximab Other Phase PHASE1 Myeloma Multiple ClinicalTrials.gov
    MEDI0618 Other Phase PHASE2 Migraine ClinicalTrials.gov
    Quality-of-Life Assessment Other Phase PHASE1 Myelodysplastic Syndrome ClinicalTrials.gov
    Laboratory Biomarker Analysis Other Phase PHASE1 Myelodysplastic Syndrome ClinicalTrials.gov
    Decitabine Other Phase PHASE1 Myelodysplastic Syndrome ClinicalTrials.gov
    Navitoclax Other Phase PHASE1 Myelodysplastic Syndrome ClinicalTrials.gov
    Botulinum Toxin Type A Other Phase PHASE2 Arthritis ClinicalTrials.gov
    intra-articular botulinum toxin type a Other Phase PHASE3 Arthritis ClinicalTrials.gov
    Botox Cosmetic™ Other Approved Skin Wrinkling ClinicalTrials.gov
    Trabeculectomy Other Approved Glaucoma ClinicalTrials.gov
    Argon laser trabeculoplasty Other Approved Glaucoma ClinicalTrials.gov
    Intraocular pressure reduction Other Approved Glaucoma ClinicalTrials.gov
    Tazarotene 0.1% gel + placebo capsule, Oral minocycline (100 mg capsule) + vehicle gel, Tazarotene 0.1% gel + oral minocycline (100 mg capsule) Other Phase PHASE4 Acne Vulgaris ClinicalTrials.gov
    Nepafenac (Nevanac) Other Phase PHASE4 Myopia ClinicalTrials.gov
    ketorolac (Acular LS) Other Phase PHASE4 Myopia ClinicalTrials.gov
    Zanaflex® Other Phase PHASE4 Upper Limb Spasticity ClinicalTrials.gov
    BOTOX® Other Phase PHASE4 Upper Limb Spasticity ClinicalTrials.gov
    Combigan Ophthalmic Solutiom Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    Brimonidine Purite Other Approved Cataract ClinicalTrials.gov
    Optiva artificial tear by Allergan Other Approved Dry Eye Disease ClinicalTrials.gov
    latanoprost 0.005% eye drops and brinzolamide 1.0% eye drops Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    latanoprost 0.005% eye drops and brimonidine 0.1% eye drops Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    placebo capsule Other Phase PHASE2 Diabetic Neuropathy, Painful ClinicalTrials.gov
    AGN 203818 Other Phase PHASE2 Diabetic Neuropathy, Painful ClinicalTrials.gov
    0.05% cyclosporin eye drop Other Phase PHASE4 Dry Eye ClinicalTrials.gov
    adapalene 0.3% topical gel Other Approved Acne Vulgaris ClinicalTrials.gov
    Effexor® Tablets equivalent to 50 mg venlafaxine Other Phase PHASE1 Healthy ClinicalTrials.gov
    VENLAFAXINE TABLETS 50 mg , single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Proscar® 5 mg Tablet, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Finasteride 5 mg Tablet, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    NorvasC® 10 mg Tablets Other Phase PHASE1 Healthy ClinicalTrials.gov
    AMLODIPINE (as BESILATE) TABLETS 10 mg , single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Wellbutrin XL® 150 mg Tablet, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Abrika Bupropion 150 mg XL Tablet, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Wellbutrin SR® 150 mg Extended-Release Tablet, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Abrika Bupropion 150 mg Extended-Released Tablet Other Phase PHASE1 Healthy ClinicalTrials.gov
    Wellbutrin SR® 150 mg Sustained-Release Tablet, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Bupropion 150 mg Extended-Released Tablet, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Coreg® 12.5 mg Tablets , single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Carvedilol 12.5 mg Tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Zoloft® 100 mg tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Sertraline HCl 100 mg tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Zyrtec® 10 mg tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Cetirizine Hydrochloride 10 mg tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Atlace® 10 mg capsules, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Ramipril10 mg Capsules, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Grifulvin V® 125 mg/5 mL Suspension, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Griseofulvin 125 mg/5 mL Suspension, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Sham injection Other Phase PHASE2 Intermediate Uveitis ClinicalTrials.gov
    Linaclotide Other Phase PHASE3 Functional Constipation (FC) ClinicalTrials.gov
    Placebo for Linaclotide Other Phase PHASE3 Functional Constipation (FC) ClinicalTrials.gov
    Bimatoprost 0.03% ophthalmic solution Other Phase PHASE2 Glaucoma ClinicalTrials.gov
    Bimatoprost 0.02% ophthalmic solution Other Phase PHASE2 Glaucoma ClinicalTrials.gov
    Bimatoprost 0.015% formulation 2 ophthalmic solution Other Phase PHASE2 Glaucoma ClinicalTrials.gov
    Bimatoprost 0.015% formulation 1 ophthalmic solution Other Phase PHASE2 Glaucoma ClinicalTrials.gov
    Bimatoprost 0.01% ophthalmic solution Other Phase PHASE2 Glaucoma ClinicalTrials.gov
    Brimonidine ophthalmic solution 0.2% Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    Brimonidine ophthalmic solution 0.1% Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    Brimonidine 0.2% ophthalmic solution Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    Concurrent brimonidine 0.2% and Timolol 0.5% ophthalmic solution Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    0.2% brimonidine/0.5% timolol fixed combination ophthalmic solution Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    Bimatoprost Vehicle Ophthalmic Solution Other Phase PHASE2 Glaucoma ClinicalTrials.gov
    Concurrent brimonidine 0.2% and 0.5% timolol Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    Brimonidine 0.2%/Timolol 0.5% Fixed Combination Ophthalmic Solution Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    Botulinic toxin (Botox) Other Approved Spastic Equinovarus ClinicalTrials.gov
    dorzolamide hcl 2%/timolol maleate 0.5% fixed combinatin as adjunctive to current prostaglandin therapy. Drug Phase PHASE4 Open-Angle Glaucoma ClinicalTrials.gov
    brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination as adjunctive to current prostaglandin therapy. Drug Phase PHASE4 Open-Angle Glaucoma ClinicalTrials.gov
    dorzolamide hcl 2%/ timolol maleate 0.5% fixed combination Other Phase PHASE4 Open-Angle Glaucoma ClinicalTrials.gov
    brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination Other Phase PHASE4 Open-Angle Glaucoma ClinicalTrials.gov
    dorzolamide hcl 2%/timolol maleate 0.5% fixed combination as adjunctive to current prostaglandin therapy Drug Phase PHASE4 Open-Angle Glaucoma ClinicalTrials.gov
    brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination as adjunctive to current prostaglandin therapy Drug Phase PHASE4 Open-Angle Glaucoma ClinicalTrials.gov
    dorzolamide hcl 2%/timolol maleate 0.5% fixed combination Other Phase PHASE4 Open-Angle Glaucoma ClinicalTrials.gov
    ketorolac Other Phase PHASE3 Cataract Extraction ClinicalTrials.gov
    ketorolac eye drops Other Phase PHASE3 Cataract Extraction ClinicalTrials.gov
    Carboxymethylcellulose Other Approved Dry Eye Syndrome ClinicalTrials.gov
    Carboxymethylcellulose and Glycerin based artificial tear Other Approved Dry Eye Syndrome ClinicalTrials.gov
    CELEXATM 10 mg tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Citalopram HBr eq. 10 mg tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    ADALAT® CC Extended Release Tablets 60 mg Other Phase PHASE1 Healthy ClinicalTrials.gov
    Nifedipine Extended Release tablets 60 mg, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    GLUCOPHAGE® XR 750 mg tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Metformin HCl 750 mg Extender Release tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    CLUCOPHAGE® XR 500 mg tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Metformin HCl 500 mg tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    XANAX XR® 3 mg tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Alprazolam 3 mg Extended Release Tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    REMERON® 15 mg tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Mirtazapine 15 mg tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    NEURONTIN® 800 mg Tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Gabapentin 800 mg Tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Ultravate® 0.05% ointment, single exposure Other Phase PHASE1 Healthy ClinicalTrials.gov
    CLUCOVANCE® 5 mg/500 mg Tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Glyburide and Metformin Hydrochloride Tablets 5 mg/500 mg Other Phase PHASE1 Healthy ClinicalTrials.gov
    INDERAL® LA 160 mg Capsules, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Propranolol Hydrochloride Extended Release Capsules 160 mg Other Phase PHASE1 Healthy ClinicalTrials.gov
    CelexaTM 40 mg tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Citalopram HBr 40 mg tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    NEURONTIN® 400 mg capsules, single dose (2 capsules) Other Phase PHASE1 Healthy ClinicalTrials.gov
    Gabapentin 800 mg tablets, single dose (1 tablet) Other Phase PHASE1 Healthy ClinicalTrials.gov
    COMBONOX® tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Oxycodone HCl 5 mg / Ibuprofen 400 mg tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Gabapentin 400 mg capsules, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    NEURONTIN® 400 mg capsules Other Phase PHASE1 Healthy ClinicalTrials.gov
    Gabapentin 400 mg capsules Other Phase PHASE1 Healthy ClinicalTrials.gov
    KADIAN (morphine sulfate extended-release) capsules Other Phase PHASE1 Healthy ClinicalTrials.gov
    morphine sulfate extended-release capsules Other Phase PHASE1 Healthy ClinicalTrials.gov
    NIRAVAM TM 2 mg orally disintegrating tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    ALPRAZOLAM ORALLY DISINTEGRATING TABLETS, 2.0 MG Other Phase PHASE1 Healthy ClinicalTrials.gov
    memantine Other Phase PHASE3 Open-Angle Glaucoma ClinicalTrials.gov
    Vehicle Control Other Approved MILD TO SEVERE ACNE VULGARIS ClinicalTrials.gov
    ZIANA® Other Approved MILD TO SEVERE ACNE VULGARIS ClinicalTrials.gov
    CLIND PHOSPHATE (1.2%) AND TRETINOIN (0.025%) TOPICAL GEL Other Approved MILD TO SEVERE ACNE VULGARIS ClinicalTrials.gov
    Botulinum Toxin Type A injection (BOTOX) Other Phase PHASE2 Thoracic Outlet Syndrome ClinicalTrials.gov
    Emulsion type artificial tear Other Phase PHASE3 Dry Eye ClinicalTrials.gov
    ACZONE (dapsone) Gel, 5%, 1x/day (AM) + MetroGel (metronidazole gel), 1.0%, 1x/day (PM) Other Phase PHASE2 Rosacea ClinicalTrials.gov
    MetroGel® (metronidazole gel), 1.0% 1x/day Other Phase PHASE2 Rosacea ClinicalTrials.gov
    ACZONE (dapsone) Gel, 5%, 1x/day Other Phase PHASE2 Rosacea ClinicalTrials.gov
    ACZONE (dapsone) Gel, 5%, 2x/day Other Phase PHASE2 Rosacea ClinicalTrials.gov
    Vehicle control, 2x/day Other Phase PHASE2 Rosacea ClinicalTrials.gov
    Carboxymethylcellulose sodium and Glycerin Other Phase PHASE2 Dry Eye ClinicalTrials.gov
    Vehicle Other Phase PHASE4 Acne Vulgaris ClinicalTrials.gov
    ACZONE Gel, 5% Other Phase PHASE4 Acne Vulgaris ClinicalTrials.gov
    brimonidine Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    Dapsone Topical Gel + vehicle control Other Phase PHASE3 Acne Vulgaris ClinicalTrials.gov
    Dapsone Topical Gel + benzoyl peroxide gel 4% Other Phase PHASE3 Acne Vulgaris ClinicalTrials.gov
    Dapsone Topical Gel + adapalene gel 0.1% Other Phase PHASE3 Acne Vulgaris ClinicalTrials.gov
    DEX PS DDS® Other Phase PHASE2 Diabetes ClinicalTrials.gov
    Ophthalmic Emulsion Other Phase PHASE3 Keratoconjunctivitis Sicca ClinicalTrials.gov
    Refresh Contacts Other Approved Dry Eye ClinicalTrials.gov
    Refresh Dry Eye Therapy Drug Approved Dry Eye ClinicalTrials.gov
    Next Generation Emulsion Other Approved Dry Eye ClinicalTrials.gov
    nepafenac Other Phase PHASE4 Cataracts ClinicalTrials.gov
    Bromfenac Other Phase PHASE4 Cataracts ClinicalTrials.gov
    Ketorolac Tromethamine Other Phase PHASE4 Cataracts ClinicalTrials.gov
    olopatadine hydrochloride 0.1% ophthalmic solution Other Phase PHASE3 Rhinitis, Allergic, Seasonal ClinicalTrials.gov
    olopatadine hydrochloride /ketorolac tromethamine fixed dose combination ophthalmic solution Other Phase PHASE3 Rhinitis, Allergic, Seasonal ClinicalTrials.gov
    ABBV-383 (Etentamig) Other Phase PHASE1 Immunoglobulin Light Chain (AL) Amyloidosis ClinicalTrials.gov
    Nab-Paclitaxel and gemcitabine Other Phase PHASE2 Pancreatic Cancer ClinicalTrials.gov
    TTX-030, budigalimab, nab-paclitaxel and gemcitabine Other Phase PHASE2 Pancreatic Cancer ClinicalTrials.gov
    TTX-030, nab-paclitaxel and gemcitabine Other Phase PHASE2 Pancreatic Cancer ClinicalTrials.gov
    ACZONE (dapsone) Gel, 5% Other Phase PHASE2 Rash ClinicalTrials.gov
    bimatoprost/timolol fixed combination Other Phase PHASE3 Ocular Hypertension ClinicalTrials.gov
    brimonidine/timolol fixed combination Other Phase PHASE3 Ocular Hypertension ClinicalTrials.gov
    bimatoprost Other Phase PHASE2 Ocular Hypertension ClinicalTrials.gov
    esomeprazole Other Phase PHASE1 Peptic Ulcer ClinicalTrials.gov
    AGN 201904 Other Phase PHASE1 Peptic Ulcer ClinicalTrials.gov
    alacaftadine and naphazoline HCl & pheniramine maleate Other Phase PHASE4 Allergic Conjunctivitis ClinicalTrials.gov
    sodium hyaluronate 0.18% (VISMED® Multi) Other Phase PHASE4 Dry Eye Syndromes ClinicalTrials.gov
    carboxymethylcellulose 0.5% , glycerin 0.9% (OPTIVE® MD) Other Phase PHASE4 Dry Eye Syndromes ClinicalTrials.gov
    moxifloxacin 0.5% eye drops Other Phase PHASE4 Bacterial Conjunctivitis ClinicalTrials.gov
    gatifloxacin Other Phase PHASE4 Bacterial Conjunctivitis ClinicalTrials.gov
    Lubricating Eye Drop Other Phase PHASE4 Inflammation ClinicalTrials.gov
    Ketorolac 0.4% Other Phase PHASE4 Inflammation ClinicalTrials.gov
    nepafenac 0.1% Other Phase PHASE4 Cataracts ClinicalTrials.gov
    bromfenac 0.09% Other Phase PHASE4 Cataracts ClinicalTrials.gov
    Ketorolac Tromethamine 0.45% Other Phase PHASE4 Cataracts ClinicalTrials.gov
    latanoprost 0.005% eye drops Other Phase PHASE4 Ocular Hypertension ClinicalTrials.gov
    bimatoprost 0.03% eye drops Other Phase PHASE4 Ocular Hypertension ClinicalTrials.gov
    sodium hyaluronate 0.18% Other Phase PHASE4 Dry Eye Syndromes ClinicalTrials.gov
    carboxymethylcellulose 0.5% +glycerin 0.9% Other Phase PHASE4 Dry Eye Syndromes ClinicalTrials.gov
    Tretinoin Other Phase PHASE4 Acne Vulgaris ClinicalTrials.gov
    Dapsone; Tretinoin Other Phase PHASE4 Acne Vulgaris ClinicalTrials.gov
    Tazarotene Other Phase PHASE4 Acne Vulgaris ClinicalTrials.gov
    Dapsone Other Phase PHASE4 Acne Vulgaris ClinicalTrials.gov
    Lubricating Eye Drops (blink® Tears) Other Phase PHASE4 Dry Eye Syndromes ClinicalTrials.gov
    Lubricant Eye Drops (Optive™) Other Phase PHASE4 Dry Eye Syndromes ClinicalTrials.gov
    placebo eye drops Other Phase PHASE3 Bacterial Conjunctivitis ClinicalTrials.gov
    Gatifloxacin 0.5% eye drops Other Phase PHASE3 Bacterial Conjunctivitis ClinicalTrials.gov
    bimatoprost ophthalmic solution 0.03% Other Phase PHASE2 Eyelash Hypotrichosis ClinicalTrials.gov
    bimatoprost ophthalmic solution 0.015% Other Phase PHASE2 Eyelash Hypotrichosis ClinicalTrials.gov
    bimatoprost ophthalmic solution 0.005% Other Phase PHASE2 Eyelash Hypotrichosis ClinicalTrials.gov
    Metformin hydrochloride (Glucophage®) Other Phase PHASE1 Healthy ClinicalTrials.gov
    Trospium Chloride (Sanctura XR®) Other Phase PHASE1 Healthy ClinicalTrials.gov
    gatifloxacin ophthalmic solution 0.3% Other Phase PHASE4 Anti-biotic Resistance ClinicalTrials.gov
    moxifloxacin 0.5% HCI ophthalmic solution Other Phase PHASE4 Anti-biotic Resistance ClinicalTrials.gov
    Artificial Tears REFRESH ENDURA® Other Phase PHASE2 Dry Eye Syndromes ClinicalTrials.gov
    Cyclosporine Ophthalmic Emulsion 0.05% (RESTASIS®) Other Phase PHASE2 Dry Eye Syndromes ClinicalTrials.gov
    Placebo (Vehicle Gel) Other Approved Acne Vulgaris ClinicalTrials.gov
    EPIDUO Other Approved Acne Vulgaris ClinicalTrials.gov
    adapalene 0.1% and benzoyl peroxide 2.5% topical gel Other Approved Acne Vulgaris ClinicalTrials.gov
    imiquimod cream, 3.75% Other Approved Actinic Keratoses ClinicalTrials.gov
    Vehicle Cream Other Approved Actinic Keratoses ClinicalTrials.gov
    vehicle sterile solution (placebo) Other Phase PHASE4 Hypotrichosis ClinicalTrials.gov
    bimatoprost ophthalmic 0.03% solution Other Phase PHASE4 Hypotrichosis ClinicalTrials.gov
    bimatoprost 0.03%, latanoprost 0.005%, and travoprost 0.004% Other Preclinical Open-Angle Glaucoma ClinicalTrials.gov
    cyclosporine ophthalmic emulsion 0.05%, artificial tears Other Preclinical Keratoconjunctivitis Sicca ClinicalTrials.gov
    topical bimatoprost Other Phase PHASE4 Hypotrichosis ClinicalTrials.gov
    cyclosporine ophthalmic emulsion 0.05% Other Phase PHASE2 Pterygium ClinicalTrials.gov
    Cataract Surgery and Limbal relaxing incision Procedure Preclinical Dry Eye ClinicalTrials.gov
    Fluorometholone Eye Drops (FML Forte®) Other Phase PHASE2 Epiphora ClinicalTrials.gov
    Lubricant Eye Drops (Refresh Endura™) Other Phase PHASE2 Epiphora ClinicalTrials.gov
    Cyclosporine Eye Drops (Restasis) Other Phase PHASE2 Epiphora ClinicalTrials.gov
    Botulinum Toxin Type A 900kD Other Phase PHASE4 Muscle Spasticity ClinicalTrials.gov
    700 ug dexamethasone Other Phase PHASE2 Subfoveal Choroidal Neovascularization ClinicalTrials.gov
    Vehicle solution Other Phase PHASE3 Hypotrichosis ClinicalTrials.gov
    Bimatoprost 0.03% solution Other Phase PHASE3 Hypotrichosis ClinicalTrials.gov
    Any Fixed Combination Therapy Drug Preclinical Glaucoma, Open-Angle ClinicalTrials.gov
    bimatoprost 0.01% Other Preclinical Glaucoma, Open-Angle ClinicalTrials.gov
    Fixed combination 0.3 mg bimatoprost and 5 mg timolol Other Preclinical Glaucoma, Open-Angle ClinicalTrials.gov
    normal saline (placebo) Other Phase PHASE4 Glabellar Frown Lines ClinicalTrials.gov
    No treatment Drug Preclinical Healthy Volunteers ClinicalTrials.gov
    No Intervention Other Preclinical Healthy Volunteers ClinicalTrials.gov
    BOTULINUM NEUROTOXIN TYPE-A Other Phase PHASE2 Sialorrhea ClinicalTrials.gov
    Cyclosporine 0.010% Other Phase PHASE3 Atopic Conjunctivitis ClinicalTrials.gov
    Cyclosporine Vehicle Other Phase PHASE3 Atopic Conjunctivitis ClinicalTrials.gov
    ABT-869 Other Phase PHASE2 Advanced Colorectal Cancer ClinicalTrials.gov
    folinic acid Other Phase PHASE2 Advanced Colorectal Cancer ClinicalTrials.gov
    bimatoprost vehicle solution Other Phase PHASE4 Hypotrichosis ClinicalTrials.gov
    Refresh® Dry Eye therapy Drug Phase PHASE2 Brittle Nails ClinicalTrials.gov
    Restasis (cyclosporine ophthalmic emulsion) 0.05% Other Phase PHASE2 Brittle Nails ClinicalTrials.gov
    bimatoprost vehicle Other Phase PHASE2 Glaucoma, Open-Angle ClinicalTrials.gov
    AGN-210669 Other Phase PHASE2 Glaucoma, Open-Angle ClinicalTrials.gov
    Ketoconazole Other Phase PHASE1 Healthy ClinicalTrials.gov
    IV DHE Other Phase PHASE1 Healthy ClinicalTrials.gov
    MAP0004 Other Phase PHASE1 Healthy ClinicalTrials.gov
    dextran 70 0.1%/hydroxypropyl methylcellulose 0.3% Other Phase PHASE4 Conjunctivitis, Allergic ClinicalTrials.gov
    Olopatadine 0.2% Other Phase PHASE4 Conjunctivitis, Allergic ClinicalTrials.gov
    Alcaftadine 0.25% Other Phase PHASE4 Conjunctivitis, Allergic ClinicalTrials.gov
    OPTIVE PLUS® Other Preclinical Dry Eye Syndromes ClinicalTrials.gov
    Tear Sample Collection Other Preclinical Healthy Volunteers ClinicalTrials.gov
    botulinum toxin Type A (100U); botulinum toxin Type A (200U) Other Phase PHASE2 Overactive Bladder ClinicalTrials.gov
    botulinum toxin Type A (200U) Other Phase PHASE2 Overactive Bladder ClinicalTrials.gov
    botulinum toxin Type A (50U); botulinum toxin Type A (200U) Other Phase PHASE2 Overactive Bladder ClinicalTrials.gov
    Normal saline (Placebo); botulinum toxin Type A (200U) Other Phase PHASE2 Overactive Bladder ClinicalTrials.gov
    Neurological Examination Other Preclinical Spasticity, Muscle ClinicalTrials.gov
    Belotero Balance® Other Approved Patients With Moderate to Severe Perioral Lines ClinicalTrials.gov
    JUVEDERM® Ultra XC Other Approved Patients With Moderate to Severe Perioral Lines ClinicalTrials.gov
    Punctal Plug Other Phase PHASE4 Dry Eye ClinicalTrials.gov
    700 μg Dexamethasone Other Phase PHASE3 Macular Edema ClinicalTrials.gov
    350 µg Dexamethasone Other Phase PHASE3 Macular Edema ClinicalTrials.gov
    700 µg Dexamethasone Other Phase PHASE3 Macular Edema ClinicalTrials.gov
    Wild Blueberry extract 100mg Other Approved Cognitive Decline ClinicalTrials.gov
    Wild Blueberry Powder - 450mg Other Approved Cognitive Decline ClinicalTrials.gov
    Wild Blueberry Powder - 900 mg Other Approved Cognitive Decline ClinicalTrials.gov
    Fumaderm Other Phase PHASE3 Psoriasis ClinicalTrials.gov
    adapalene 0.3% gel Other Phase PHASE1 Acne Vulgaris ClinicalTrials.gov
    dapsone 5% gel Other Phase PHASE1 Acne Vulgaris ClinicalTrials.gov
    Fixed Combination dapsone/adapalene Formulation B Gel Other Phase PHASE1 Acne Vulgaris ClinicalTrials.gov
    Fixed Combination dapsone/adapalene Formulation A Gel Other Phase PHASE1 Acne Vulgaris ClinicalTrials.gov
    Krytantek Other Preclinical Glaucoma Primary Open Angle ClinicalTrials.gov
    Ganforti Other Preclinical Glaucoma Primary Open Angle ClinicalTrials.gov
    No intervention applicable Other Preclinical Cerebral Palsy. ClinicalTrials.gov
    normal saline Other Phase PHASE2 Benign Prostatic Hyperplasia ClinicalTrials.gov
    Lidocaine Other Phase PHASE2 Diabetic Neuropathic Pain ClinicalTrials.gov
    ABT-639 Other Phase PHASE2 Diabetic Neuropathic Pain ClinicalTrials.gov
    etanercept Other Phase PHASE3 Moderate to Severe Plaque Psoriasis ClinicalTrials.gov
    ABT-874 Other Phase PHASE3 Moderate to Severe Plaque Psoriasis ClinicalTrials.gov
    ABT-089 Other Phase PHASE2 Attention-Deficit/Hyperactivity Disorder ClinicalTrials.gov
    M200 (Volociximab) Other Phase PHASE1 Ovarian Cancer, Primary Peritoneal Cancer ClinicalTrials.gov
    Liposomal Doxorubicin Other Phase PHASE1 Ovarian Cancer, Primary Peritoneal Cancer ClinicalTrials.gov
    Anti IL-12 monoclonal antibody/ABT-874 Other Phase PHASE2 Psoriasis ClinicalTrials.gov
    Trospium Chloride, Extended Release (XR) Other Phase PHASE4 Obesity ClinicalTrials.gov
    Duloxetine Other Phase PHASE2 Diabetic Neuralgia ClinicalTrials.gov
    ABT-894 Other Phase PHASE2 Diabetic Neuralgia ClinicalTrials.gov
    Placebo for ABT-869 Other Phase PHASE2 Metastatic Breast Cancer ClinicalTrials.gov
    latanoprost Other Phase PHASE4 Glaucoma, Angle-Closure ClinicalTrials.gov
    Saline Other Phase PHASE4 Chronic Migraine ClinicalTrials.gov
    dexamethasone intravitreal implant 0.7 mg Other Preclinical Macular Edema ClinicalTrials.gov
    olopatadine 0.2% ophthalmic solution Other Phase PHASE4 Conjunctivitis, Allergic ClinicalTrials.gov
    alcaftadine 0.25% ophthalmic solution Other Phase PHASE4 Conjunctivitis, Allergic ClinicalTrials.gov
    Dapsone Formulation C Other Phase PHASE1 Acne Vulgaris ClinicalTrials.gov
    Dapsone Formulation B Other Phase PHASE1 Acne Vulgaris ClinicalTrials.gov
    Dapsone Formulation A Other Phase PHASE1 Acne Vulgaris ClinicalTrials.gov
    lopinavir/ritonavir Other Phase PHASE4 Human Immunodeficiency Virus ClinicalTrials.gov
    bimatoprost/timolol fixed combination ophthalmic solution Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    bimatoprost /timolol formulation A fixed combination ophthalmic solution Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    ABT-072 Other Phase PHASE2 Hepatitis C Virus Infection ClinicalTrials.gov
    ABT-869 0.10 mg/kg Other Phase PHASE2 Non-Small Cell Lung Cancer (NSCLC) ClinicalTrials.gov
    ABT-869 .25 mg/kg Other Phase PHASE2 Non-Small Cell Lung Cancer (NSCLC) ClinicalTrials.gov
    Sham (no implant) Other Phase PHASE1 Retinitis Pigmentosa ClinicalTrials.gov
    100 µg Brimonidine Tartrate Implant Other Phase PHASE1 Retinitis Pigmentosa ClinicalTrials.gov
    200 µg Brimonidine Tartrate Implant Other Phase PHASE1 Retinitis Pigmentosa ClinicalTrials.gov
    400 µg Brimonidine Tartrate Implant Other Phase PHASE1 Retinitis Pigmentosa ClinicalTrials.gov
    maxacalcitol placebo Other Phase PHASE3 Secondary Hyperparathyroidism ClinicalTrials.gov
    paricalcitol placebo Other Phase PHASE3 Secondary Hyperparathyroidism ClinicalTrials.gov
    maxacalcitol Other Phase PHASE3 Secondary Hyperparathyroidism ClinicalTrials.gov
    FCR Other Phase PHASE1 Chronic Lymphocytic Leukemia ClinicalTrials.gov
    ABT-263 Other Phase PHASE1 Chronic Lymphocytic Leukemia ClinicalTrials.gov
    Palivizumab Other Phase PHASE3 Respiratory Syncytial Virus Infection ClinicalTrials.gov
    botulinum toxin A (BTX-A) Other Approved Stiff Knee Gait ClinicalTrials.gov
    Pars Plana Vitrectomy Other Preclinical Vitrectomy ClinicalTrials.gov
    Placebo (Vehicle for Cyclosporine) Other Phase PHASE2 Laser In Situ Keratomileusis ClinicalTrials.gov
    Cyclosporine 0.005% eye drops Other Phase PHASE2 Laser In Situ Keratomileusis ClinicalTrials.gov
    Cyclosporine 0.010% eye drops Other Phase PHASE2 Laser In Situ Keratomileusis ClinicalTrials.gov
    dorzolamide hydrochloride 2.0%/brimonidine tartrate 0.2%/timolol 0.5% ophthalmic solution Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    Calcitriol Other Preclinical Secondary Hyperparathyroidism ClinicalTrials.gov
    Placebo and rehab Other Phase EARLY_PHASE1 Stroke ClinicalTrials.gov
    Botox and rehab Other Phase EARLY_PHASE1 Stroke ClinicalTrials.gov
    bimatoprost Formulation C Other Phase PHASE1 Alopecia ClinicalTrials.gov
    bimatoprost Formulation B Other Phase PHASE1 Alopecia ClinicalTrials.gov
    bimatoprost Formulation A Other Phase PHASE1 Alopecia ClinicalTrials.gov
    Ozurdex Other Preclinical Macular Edema ClinicalTrials.gov
    bimatoprost/brimonidine tartrate/timolol fixed combination ophthalmic solution Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    ABT-652 12 mg - 18 mg Other Phase PHASE2 Diabetic Neuropathic Pain ClinicalTrials.gov
    ABT-652 12 mg Other Phase PHASE2 Diabetic Neuropathic Pain ClinicalTrials.gov
    ABT-652 6 mg Other Phase PHASE2 Diabetic Neuropathic Pain ClinicalTrials.gov
    Blink Contacts® Eye Drops Other Phase PHASE4 Contact Lens Related Dry Eye Syndrome ClinicalTrials.gov
    OPTIVEtm Plus Other Phase PHASE4 Contact Lens Related Dry Eye Syndrome ClinicalTrials.gov
    Placebo (saline) Other Phase PHASE1 Benign Prostatic Hyperplasia ClinicalTrials.gov
    Escitalopram Other Phase PHASE2 Major Depressive Disorder ClinicalTrials.gov
    ABT-436 Other Phase PHASE2 Major Depressive Disorder ClinicalTrials.gov
    AGN-210669 vehicle ophthalmic solution Other Phase PHASE1 Ocular Hypertension ClinicalTrials.gov
    AGN-210669 ophthalmic solution, 0.025% Other Phase PHASE1 Ocular Hypertension ClinicalTrials.gov
    AGN-210669 ophthalmic solution, 0.05% Other Phase PHASE1 Ocular Hypertension ClinicalTrials.gov
    AGN-210669 ophthalmic solution, 0.075% Other Phase PHASE1 Ocular Hypertension ClinicalTrials.gov
    vehicle sterile solution Other Phase PHASE3 Eyelashes ClinicalTrials.gov
    Bimatoprost 0.03% sterile solution Other Phase PHASE3 Eyelashes ClinicalTrials.gov
    Rehabilitation Therapy Drug Approved Upper Limb Spasticity ClinicalTrials.gov
    Botulinum toxin type A, BoNT-A Other Approved Upper Limb Spasticity ClinicalTrials.gov
    ABT-348 Other Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    ABT-348 and docetaxel Other Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    ABT-348 and carboplatin Other Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Placebo to AGN-214868 Other Phase PHASE2 Neuralgia, Postherpetic ClinicalTrials.gov
    AGN-214868 Other Phase PHASE2 Neuralgia, Postherpetic ClinicalTrials.gov
    Botulinum Toxin Type A 150kDa Other Phase PHASE4 Blepharospasm ClinicalTrials.gov
    Botulinum Toxin Type A 900kDa Other Phase PHASE4 Blepharospasm ClinicalTrials.gov
    Carboxymethylcellulose sodium, glycerin and polysorbate 80 Other Phase PHASE2 Dry Eye Syndrome ClinicalTrials.gov
    ABT-354 Other Phase PHASE1 Alzheimer's Disease ClinicalTrials.gov
    Moxifloxacin Other Phase PHASE1 Healthy ClinicalTrials.gov
    Inhaler Placebo Other Phase PHASE1 Healthy ClinicalTrials.gov
    IV Dihydroergotamine Mesylate (DHE) Other Phase PHASE1 Healthy ClinicalTrials.gov
    Placebo Inhaler Other Phase PHASE1 Healthy ClinicalTrials.gov
    IV Placebo (Saline) Other Phase PHASE1 Healthy ClinicalTrials.gov
    21ug MAP0020 Other Phase PHASE2 Asthma ClinicalTrials.gov
    42ug MAP0020 Other Phase PHASE2 Asthma ClinicalTrials.gov
    84ug MAP0020 Other Phase PHASE2 Asthma ClinicalTrials.gov
    MAP0010 high dose Other Phase PHASE2 Asthma ClinicalTrials.gov
    MAP0010 low dose Other Phase PHASE2 Asthma ClinicalTrials.gov
    0.25mg MAP0010 Other Phase PHASE3 Asthma ClinicalTrials.gov
    0.135mg MAP0010 Other Phase PHASE3 Asthma ClinicalTrials.gov
    Leuprolide Acetate 3 Month Depot Other Phase PHASE3 Precocious ClinicalTrials.gov
    MAP0010 intermediate dose Other Phase PHASE1 Asthma ClinicalTrials.gov
    Budesonide Inhalation Suspension Other Phase PHASE1 Asthma ClinicalTrials.gov
    Budesonide inhalation suspension 0.5mg Other Phase PHASE2 Asthma ClinicalTrials.gov
    Budesonide inhalation suspension 0.25mg Other Phase PHASE2 Asthma ClinicalTrials.gov
    hydrocodone/acetaminophen extended release Other Phase PHASE2 Chronic Low Back Pain ClinicalTrials.gov
    ABT-333 Other Phase PHASE1 Relative Bioavailability ClinicalTrials.gov
    vehicle of AGN-229666 Other Phase PHASE2 Allergic Conjunctivitis ClinicalTrials.gov
    AGN-229666 Other Phase PHASE2 Allergic Conjunctivitis ClinicalTrials.gov
    ABT-712 Other Phase PHASE3 Chronic Low Back Pain ClinicalTrials.gov
    ABT-450/r/ABT-267 Other Phase PHASE1 Absolute Bioavailability ClinicalTrials.gov
    onabotulinumtoxinA 24 U Other Phase PHASE3 Facial Rhytides ClinicalTrials.gov
    onabotulinumtoxinA 44 U Other Phase PHASE3 Facial Rhytides ClinicalTrials.gov
    Hydrocodone/Acetaminophen Immediate-release Other Phase PHASE2 Pain ClinicalTrials.gov
    ABT-712 Extended-release Other Phase PHASE2 Pain ClinicalTrials.gov
    minoxidil 2% solution Other Phase PHASE2 Alopecia ClinicalTrials.gov
    minoxidil 5% solution Other Phase PHASE2 Alopecia ClinicalTrials.gov
    Relestat Ophthalmic Solution 0.05% Other Preclinical Conjunctivitis, Allergic ClinicalTrials.gov
    EMG Guidance of Injection Other Approved High Tone Pelvic Floor Dysfunction ClinicalTrials.gov
    Rifampin Other Phase PHASE1 Non-Hodgkin's Lymphoma ClinicalTrials.gov
    ABT-199 Other Phase PHASE1 Non-Hodgkin's Lymphoma ClinicalTrials.gov
    ABT-SLV176 Other Phase PHASE3 Hypogonadism ClinicalTrials.gov
    ABT-719 Other Phase PHASE2 Cardiothoracic Surgery ClinicalTrials.gov
    Adalimumab, new formulation Other Phase PHASE2 Rheumatoid Arthritis ClinicalTrials.gov
    Adalimumab, current formulation Other Phase PHASE2 Rheumatoid Arthritis ClinicalTrials.gov
    Functional Electrical Stimulation (FES) through the Ness H200 Other Approved Upper Extremity Spasticity ClinicalTrials.gov
    Tazorac Other Phase PHASE4 Brittle Nails ClinicalTrials.gov
    0.03% Bimatoprost Other Phase PHASE4 Glaucoma, Open-Angle ClinicalTrials.gov
    AGN-210961 Formulation 7 Other Phase PHASE2 Ocular Hypertension ClinicalTrials.gov
    AGN-210961 Formulation 6 Other Phase PHASE2 Ocular Hypertension ClinicalTrials.gov
    AGN-210961 Formulation 5 Other Phase PHASE2 Ocular Hypertension ClinicalTrials.gov
    AGN-210961 Formulation 4 Other Phase PHASE2 Ocular Hypertension ClinicalTrials.gov
    AGN-210961 Formulation 3 Other Phase PHASE2 Ocular Hypertension ClinicalTrials.gov
    AGN-210961 Formulation 2 Other Phase PHASE2 Ocular Hypertension ClinicalTrials.gov
    AGN-210961 Formulation 1 Other Phase PHASE2 Ocular Hypertension ClinicalTrials.gov
    [14C]ABT-199 (GDC-0199) Other Phase PHASE1 Relapsed/Refractory Non-Hodgkin's Lymphoma ClinicalTrials.gov
    Open-label Adalimumab Other Phase PHASE3 Axial Spondyloarthritis ClinicalTrials.gov
    Fixed Combination 0.2% brimonidine tartrate/0.5% timolol ophthalmic solution Other Phase PHASE3 Glaucoma, Open-Angle ClinicalTrials.gov
    bimatoprost/brimonidine tartrate/timolol ophthalmic solution (Triple Combination Therapy) Drug Phase PHASE3 Glaucoma, Open-Angle ClinicalTrials.gov
    Easyband (Telemetrically adjustable gastric banding device) Device Approved Morbid Obesity ClinicalTrials.gov
    Crosslinked hyaluronic acid gel (Juvéderm VOLUMA®) Other Preclinical Age-related Volume Deficit in the Mid-face ClinicalTrials.gov
    hyaluronic acid gel Other Approved Lip Enhancement ClinicalTrials.gov
    Easyband® Other Preclinical Morbid Obesity ClinicalTrials.gov
    Natrelle(TM) Silicone-Filled Breast Implants Other Approved Breast Reconstruction ClinicalTrials.gov
    Style 410 Silicone-Filled Breast Implants Other Approved Breast Augmentation ClinicalTrials.gov
    Track B Other Phase PHASE4 Hypotrichosis ClinicalTrials.gov
    Track A Other Phase PHASE4 Hypotrichosis ClinicalTrials.gov
    Brimonidine Tartrate Ophthalmic Solution 0.2% Other Phase PHASE2 Glaucoma ClinicalTrials.gov
    Vehicle Ophthalmic Solution Other Phase PHASE2 Glaucoma ClinicalTrials.gov
    Bimatoprost Ophthalmic Solution 0.01% Other Phase PHASE2 Glaucoma ClinicalTrials.gov
    Fixed-Combination Bimatoprost/Brimonidine Other Phase PHASE2 Glaucoma ClinicalTrials.gov
    BTX-A Other Phase PHASE2 Primary Focal Hyperhidrosis of the Hands ClinicalTrials.gov
    botulinum toxin Type A (32U) Other Phase PHASE3 Upper Facial Rhytides ClinicalTrials.gov
    botulinum toxin Type A (44U) Other Phase PHASE3 Upper Facial Rhytides ClinicalTrials.gov
    vehicle of bimatoprost solution 0.03 % Other Phase PHASE3 Idiopathic Eyelash Hypotrichosis ClinicalTrials.gov
    vehicle of bimatoprost formulation A solution Other Phase PHASE3 Idiopathic Eyelash Hypotrichosis ClinicalTrials.gov
    bimatoprost solution 0.03 % Other Phase PHASE3 Idiopathic Eyelash Hypotrichosis ClinicalTrials.gov
    bimatoprost formulation A solution Other Phase PHASE3 Idiopathic Eyelash Hypotrichosis ClinicalTrials.gov
    Ozurdex Intravitreal Injection (0.7 mg) Other Phase PHASE4 Macular Edema ClinicalTrials.gov
    LAP-BAND® Adjustable Gastric Band (LAGB®) Other Phase PHASE2 Obesity ClinicalTrials.gov
    Intravitreal dexamethasone 0.7mg implant Other Phase PHASE4 Diabetes Mellitus ClinicalTrials.gov
    tazarotene cream 0.1% Other Phase PHASE1 Acne Vulgaris ClinicalTrials.gov
    tazarotene gel 0.1% Other Phase PHASE1 Acne Vulgaris ClinicalTrials.gov
    AGN-190168 Formulation 2 Other Phase PHASE1 Acne Vulgaris ClinicalTrials.gov
    AGN-190168 Formulation 1 Other Phase PHASE1 Acne Vulgaris ClinicalTrials.gov
    Standard Therapy Drug Approved Stroke ClinicalTrials.gov
    Optimal muscle activation therapy Drug Approved Stroke ClinicalTrials.gov
    Saline injection Other Phase PHASE4 Graves Ophthalmopathy ClinicalTrials.gov
    Treatment with Botox Drug Phase PHASE4 Essential Axillary Hyperhidrosis ClinicalTrials.gov
    Suction curettage Other Phase PHASE4 Essential Axillary Hyperhidrosis ClinicalTrials.gov
    Placebo Drug Delivery System Drug Phase PHASE1 Cataract ClinicalTrials.gov
    Dexamethasone Drug Delivery System Drug Phase PHASE1 Cataract ClinicalTrials.gov
    sham procedure Procedure Phase PHASE2 Macular Edema ClinicalTrials.gov
    abicipar pegol Other Phase PHASE2 Macular Edema ClinicalTrials.gov
    Carboxymethylcellulose sodium Other Phase PHASE2 Ametropia ClinicalTrials.gov
    Anatomically shaped silicone gel-filled breast implants Other Approved Breast Augmentation ClinicalTrials.gov
    AGN-207281 vehicle ophthalmic solution (Placebo) Other Phase PHASE1 Glaucoma, Open-Angle ClinicalTrials.gov
    timolol ophthalmic solution 0.5% Other Phase PHASE1 Glaucoma, Open-Angle ClinicalTrials.gov
    AGN-207281 ophthalmic solutions (0.1% and 0.3%); AGN-207281 vehicle ophthalmic solution (placebo) Other Phase PHASE1 Glaucoma, Open-Angle ClinicalTrials.gov
    Formulation 2: Carboxymethylcellulose sodium, glycerin, and Polysorbate 80 based artificial tear Other Approved Dry Eye Syndrome ClinicalTrials.gov
    Formulation 1: Carboxymethylcellulose sodium, glycerin and Polysorbate 80, based artificial tear Other Approved Dry Eye Syndrome ClinicalTrials.gov
    Glycerin and Polysorbate 80 based artificial tear Other Approved Dry Eye Syndrome ClinicalTrials.gov
    Dapsone Gel Other Phase PHASE4 Acne Vulgaris ClinicalTrials.gov
    Formulation 2: Carboxymethylcellulose Sodium, Glycerin and Polysorbate 80, based artificial tear Other Approved Dry Eye Syndrome ClinicalTrials.gov
    cyclosporine ophthalmic emulsion Formulation A; cyclosporine ophthalmic emulsion Formulation B Other Phase PHASE1 Dry Eye Syndromes ClinicalTrials.gov
    cyclosporine ophthalmic emulsion Formulation B; cyclosporine ophthalmic emulsion 0.05% Other Phase PHASE1 Dry Eye Syndromes ClinicalTrials.gov
    cyclosporine ophthalmic emulsion Formulation A; cyclosporine ophthalmic emulsion 0.05% Other Phase PHASE1 Dry Eye Syndromes ClinicalTrials.gov
    cyclosporine ophthalmic emulsion Formulation B Other Phase PHASE1 Dry Eye Syndromes ClinicalTrials.gov
    cyclosporine ophthalmic emulsion Formulation A Other Phase PHASE1 Dry Eye Syndromes ClinicalTrials.gov
    Ranibizumab 500µg Other Phase PHASE2 Choroid Neovascularization ClinicalTrials.gov
    AGN 211745 Other Phase PHASE2 Choroid Neovascularization ClinicalTrials.gov
    Sham Cystoscopy Procedure Procedure Phase PHASE2 Interstitial Cystitis ClinicalTrials.gov
    LiRIS Placebo Other Phase PHASE2 Interstitial Cystitis ClinicalTrials.gov
    Lidocaine Releasing Intravesical System - LiRIS® Other Phase PHASE2 Interstitial Cystitis ClinicalTrials.gov
    bimatoprost/timolol Other Preclinical Glaucoma, Open-Angle ClinicalTrials.gov
    timolol ophthalmic solution Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    bimatoprost ophthalmic solution formulation A Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    Normal saline (Placebo); botulinum toxin Type A (300U) Other Phase PHASE3 Overactive Bladder ClinicalTrials.gov
    botulinum toxin Type A (300U) Other Phase PHASE3 Overactive Bladder ClinicalTrials.gov
    Juvéderm® VOLUMA XC Other Approved Mid-facial Volume Deficit Related to Aging ClinicalTrials.gov
    hypromellose 0.3% Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    timolol 0.5% Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    travatan 0.004% Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    AGN-199201 Vehicle Other Phase PHASE2 Presbyopia ClinicalTrials.gov
    AGN-190584 Other Phase PHASE2 Presbyopia ClinicalTrials.gov
    AGN-199201 Other Phase PHASE2 Presbyopia ClinicalTrials.gov
    LiRIS® 400 mg Other Phase PHASE1 Chronic Interstitial Cystitis ClinicalTrials.gov
    botulinum toxin type A Formulation 2 Other Phase PHASE2 Cervical Dystonia ClinicalTrials.gov
    travoprost 0.004% Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    NRX-1074 Other Phase PHASE1 Healthy ClinicalTrials.gov
    LiRIS 400 mg Other Phase PHASE2 Interstitial Cystitis ClinicalTrials.gov
    NRX-1074 750 mg Other Phase PHASE1 Major Depressive Disorder ClinicalTrials.gov
    NRX-1074 500 mg Other Phase PHASE1 Major Depressive Disorder ClinicalTrials.gov
    NRX-1074 375 mg Other Phase PHASE1 Major Depressive Disorder ClinicalTrials.gov
    AGN201781 Other Phase PHASE2 Neuralgia ClinicalTrials.gov
    Trospium Chloride Other Phase PHASE4 Elderly ClinicalTrials.gov
    Vocal Exercise Other Approved Spasmodic Dysphonia ClinicalTrials.gov
    Cross-linked hyaluronic acid gel Other Approved Mid-face Volume Deficiency ClinicalTrials.gov
    Photographic Review Other Preclinical Healthy Volunteers ClinicalTrials.gov
    dexamethasone intravitreal implant Other Preclinical Macular Edema ClinicalTrials.gov
    NRX-1074 10 mg Other Phase PHASE2 Major Depressive Disorder ClinicalTrials.gov
    NRX-1074 5 mg Other Phase PHASE2 Major Depressive Disorder ClinicalTrials.gov
    NRX-1074 1 mg Other Phase PHASE2 Major Depressive Disorder ClinicalTrials.gov
    GLYX-13 10 mg/kg Other Phase PHASE2 Major Depressive Disorder ClinicalTrials.gov
    GLYX-13 5 mg/kg Other Phase PHASE2 Major Depressive Disorder ClinicalTrials.gov
    Bimatoprost Solution 2 Other Phase PHASE2 Alopecia ClinicalTrials.gov
    Bimatoprost Solution 1 Other Phase PHASE2 Alopecia ClinicalTrials.gov
    injection of botulinum toxin type A. Other Phase PHASE1 Psoriasis Vulgaris ClinicalTrials.gov
    AGN-223575 Vehicle Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    AGN-223575 Formulation C Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    AGN-223575 Formulation B Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    AGN-223575 Formulation A Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Tafluprost Unit Dose Preservative Free 15microgram/ml Other Phase PHASE4 Ocular Hypertension ClinicalTrials.gov
    Preserved Bimatoprost 0.01% Other Phase PHASE4 Ocular Hypertension ClinicalTrials.gov
    Systematic Screening and Education Regimen Other Phase PHASE4 Multiple Sclerosis ClinicalTrials.gov
    dexamethasone 700 ㎍ intravitreal implant Other Preclinical Macular Edema ClinicalTrials.gov
    ABT-122 Other Phase PHASE2 Psoriatic Arthritis ClinicalTrials.gov
    Botulinum toxin serotype A Other Phase PHASE4 Cervicobrachial Neuralgia ClinicalTrials.gov
    Plicated-LAGB Other Approved Morbid Obesity ClinicalTrials.gov
    Standard-LAGB Other Approved Morbid Obesity ClinicalTrials.gov
    AGN-232411 Vehicle Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    AGN-232411 Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    4mg triamcinolone acetonide Other Phase PHASE3 Diabetic Macular Edema ClinicalTrials.gov
    1mg triamcinolone acetonide Other Phase PHASE3 Diabetic Macular Edema ClinicalTrials.gov
    Standard of Care Group Other Phase PHASE3 Diabetic Macular Edema ClinicalTrials.gov
    BIOCELL™ Textured 410 Implant Other Preclinical Breast Implantation ClinicalTrials.gov
    VYC-12 HA injectable gel Other Phase PHASE4 Skin Roughness ClinicalTrials.gov
    Bimatoprost 1% Formulation B Other Phase PHASE1 Androgenetic Alopecia ClinicalTrials.gov
    Bimatoprost 1% Formulation A Other Phase PHASE1 Androgenetic Alopecia ClinicalTrials.gov
    Endura (artificial tears) Other Approved Glaucoma ClinicalTrials.gov
    Restasis Other Approved Glaucoma ClinicalTrials.gov
    Ombitasvir/paritaprevir/ritonavir Other Phase PHASE3 Chronic Hepatitis C Virus ClinicalTrials.gov
    Rescue medication Drug Phase PHASE2 Migraine ClinicalTrials.gov
    MK-1602 Other Phase PHASE2 Migraine ClinicalTrials.gov
    Apaziquone Other Phase PHASE3 Bladder Cancer ClinicalTrials.gov
    sterile saline solution Other Phase PHASE3 Scleroderma ClinicalTrials.gov
    Onabotulinumtoxin A Other Phase PHASE3 Scleroderma ClinicalTrials.gov
    Genteal® Lubricant Gel Drops Other Phase PHASE3 Dry Eye Syndromes ClinicalTrials.gov
    Systane® Gel Drops Other Phase PHASE3 Dry Eye Syndromes ClinicalTrials.gov
    Carboxymethylcellulose Sodium Based Eye Drops Other Phase PHASE3 Dry Eye Syndromes ClinicalTrials.gov
    Intravenous Paricalcitol Other Phase PHASE4 Endstage Renal Disease ClinicalTrials.gov
    duvelisib Other Phase PHASE1 Lymphoma ClinicalTrials.gov
    Cystoscopic injection of Botox into the urinary bladder Other Phase PHASE4 Parkinson's Disease ClinicalTrials.gov
    topical cyclosporine ophthalmic suspension 0.05% Other Phase PHASE2 Brittle Nail Syndrome ClinicalTrials.gov
    Steroid plus NSAID eye drop combination therapy Drug Phase PHASE2 Macular Edema ClinicalTrials.gov
    placebo (normal saline) Other Phase PHASE3 Muscle Spasticity ClinicalTrials.gov
    Adalimumab PRN Other Phase PHASE3 Crohn's Disease ClinicalTrials.gov
    Cyclosporine 0.05% Ophthalmic Emulsion Other Phase PHASE4 Dry Eye Syndromes ClinicalTrials.gov
    AqueSys XEN 45 Glaucoma Implant Other Approved Glaucoma ClinicalTrials.gov
    Refresh Tears Lubricant Eye Drops (Allergan) Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    placebo (sodium chloride 0.9 mg) Other Phase PHASE3 Migraine Disorders ClinicalTrials.gov
    Co-Latanoprost Other Phase PHASE4 POAG ClinicalTrials.gov
    Apo-Latanoprost Other Phase PHASE4 POAG ClinicalTrials.gov
    Xalatan Other Phase PHASE4 POAG ClinicalTrials.gov
    Triamcinolone Other Phase PHASE4 Fat Reduction ClinicalTrials.gov
    Sodium Deoxycholate Other Phase PHASE4 Fat Reduction ClinicalTrials.gov
    Positron emission tomography (PET) Other Phase PHASE2 Alzheimer's Disease ClinicalTrials.gov
    CPC-201 Other Phase PHASE2 Alzheimer's Disease ClinicalTrials.gov
    Restylane® Other Approved Nasolabial Fold ClinicalTrials.gov
    JUVÉDERM® VOLIFT® with Lidocaine Other Approved Nasolabial Fold ClinicalTrials.gov
    Botulinum toxin type A Dose 2 Other Phase PHASE3 Migraine Disorders ClinicalTrials.gov
    Botulinum toxin type A Dose 1 Other Phase PHASE3 Migraine Disorders ClinicalTrials.gov
    AGN-195263 Vehicle Other Phase PHASE2 Meibomian Gland Dysfunction ClinicalTrials.gov
    AGN-195263 0.01% Other Phase PHASE2 Meibomian Gland Dysfunction ClinicalTrials.gov
    AGN-195263 0.03% Other Phase PHASE2 Meibomian Gland Dysfunction ClinicalTrials.gov
    AGN-195263 0.1% Other Phase PHASE2 Meibomian Gland Dysfunction ClinicalTrials.gov
    ABT-493/ABT-530 Other Phase PHASE2 Chronic Hepatitis C ClinicalTrials.gov
    ribavirin (RBV) Other Phase PHASE2 Chronic Hepatitis C ClinicalTrials.gov
    ABT-493, ABT-530 Other Phase PHASE2 Chronic Hepatitis C ClinicalTrials.gov
    Botulinum toxin A + exercise Other Phase PHASE3 Patellofemoral Pain Syndrome ClinicalTrials.gov
    amblyopia therapy Drug Preclinical Amblyopia ClinicalTrials.gov
    Study Photography + Personal & Medical History Collection Other Preclinical Loss of Facial Adipose Tissue ClinicalTrials.gov
    veliparib Other Phase PHASE1 Ovarian Cancer ClinicalTrials.gov
    Whole Brain Radiation Other Phase PHASE1 Glioblastoma Multiforme ClinicalTrials.gov
    Temozolomide Other Phase PHASE1 Glioblastoma Multiforme ClinicalTrials.gov
    ABT-414 Other Phase PHASE1 Glioblastoma Multiforme ClinicalTrials.gov
    Levodopa-Carbidopa Other Phase PHASE1 Parkinson Disease ClinicalTrials.gov
    ABT-700 Other Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    erlotinib Other Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    cetuximab Other Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    FOLFIRI Other Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    linifanib Other Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    new texture shaped breast implants Other Phase PHASE4 Breast Augmentation ClinicalTrials.gov
    New texture round breast implants Other Approved Breast Augmentation ClinicalTrials.gov
    Hyaluronic Acid Injectable Gel Other Approved Chin Retrusion ClinicalTrials.gov
    3D Imaging Other Approved Hypomastia ClinicalTrials.gov
    LiRIS® Other Phase PHASE2 Cystitis, Interstitial ClinicalTrials.gov
    intra-rectal Botulinum toxin A injection Other Phase PHASE2 Low Anterior Resection Syndrome ClinicalTrials.gov
    Seri Surgical Scaffold Other Approved Recurrent Ptosis of the Breast ClinicalTrials.gov
    Dry eye exam Other Preclinical Dry Eye Syndromes ClinicalTrials.gov
    30 minutes sustained reading Other Preclinical Dry Eye Syndromes ClinicalTrials.gov
    isolated 0.3% gatifloxacin and 1.0% prednisolone acetate Other Phase PHASE3 Ocular Infection and Inflammation ClinicalTrials.gov
    0.3% gatifloxacin and 1.0% prednisolone acetate association Other Phase PHASE3 Ocular Infection and Inflammation ClinicalTrials.gov
    Valsartan 80 mg Other Phase PHASE4 Hypertension Complicated ClinicalTrials.gov
    Cyclosporine New Ophthalmic Formulation Other Phase PHASE2 Dry Eye Syndromes ClinicalTrials.gov
    Revolve System Other Approved Autologous Fat Grafting ClinicalTrials.gov
    Pegylated Interferon alpha 2-a (PegIFN) Other Phase PHASE3 Chronic Hepatitis C Infection ClinicalTrials.gov
    Telaprevir Other Phase PHASE3 Chronic Hepatitis C Infection ClinicalTrials.gov
    Ribavirin Other Phase PHASE3 Chronic Hepatitis C Infection ClinicalTrials.gov
    ABT-450/r/ABT-267, ABT-333 Other Phase PHASE3 Chronic Hepatitis C Infection ClinicalTrials.gov
    Pegylated Interferon a-2a (PegINF) Other Phase PHASE3 Chronic Hepatitis C Infection ClinicalTrials.gov
    bimatoprost 0.03% plus timolol 0.5% Other Phase PHASE4 Glaucoma, Open-Angle ClinicalTrials.gov
    Bimatoprost cutaneous solution 0.03% Other Preclinical Eyelash Hypotrichosis ClinicalTrials.gov
    Lucentis Other Phase PHASE4 Diabetic Macular Edema ClinicalTrials.gov
    brimonidine tartrate/timolol malate Ophthalmic Solution Other Phase PHASE4 Glaucoma, Open-Angle ClinicalTrials.gov
    injections on posterior bladder wall excluding the trigone Other Phase PHASE4 Interstitial Cystitis ClinicalTrials.gov
    injections upper aspect of trigone of urinary bladder Other Phase PHASE4 Interstitial Cystitis ClinicalTrials.gov
    Normal saline injection Other Phase PHASE2 Chronic Testicular Pain ClinicalTrials.gov
    Botox Injection Other Phase PHASE2 Chronic Testicular Pain ClinicalTrials.gov
    Botulinum Toxin, Type A Other Approved Muscle Strength ClinicalTrials.gov
    Marvel AM Other Approved Blue Light Damage ClinicalTrials.gov
    Deoxycholic acid Injection Other Preclinical Subcutaneous Fat ClinicalTrials.gov
    Dalbavancin Other Phase PHASE2 Osteomyelitis ClinicalTrials.gov
    Teleneurological Examination Other Preclinical Spasticity, Muscle ClinicalTrials.gov
    Simbrinza Three Times Daily (TID) Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    Combigan Two Times Daily (BID) Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    VTP-43742 Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    Placebo 2 Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    Placebo 1 Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    Ozurdex (dexamethasone) Other Phase PHASE2 Diabetes ClinicalTrials.gov
    Avastin (Bevacizumab) Other Phase PHASE2 Diabetes ClinicalTrials.gov
    AGN-195263 Other Phase PHASE3 Dry Eye Syndromes ClinicalTrials.gov
    SkinMedica Essential Defense Mineral Shield Broad Spectrum SPF 35 Sunscreen Other Approved Melasma ClinicalTrials.gov
    SkinMedica Rejuvenative Moisturizer Other Approved Melasma ClinicalTrials.gov
    SkinMedica Facial Cleanser Other Approved Melasma ClinicalTrials.gov
    4% Hydroquinone Topical Cream Other Approved Melasma ClinicalTrials.gov
    Lytera 2.0 Other Approved Melasma ClinicalTrials.gov
    Placebo-matching MK-1602 Other Phase PHASE2 Migraine ClinicalTrials.gov
    JUVÉDERM® VOLUMA® XC Other Phase PHASE4 Facial Rhytides ClinicalTrials.gov
    JUVÉDERM® ULTRA PLUS XC Other Phase PHASE4 Facial Rhytides ClinicalTrials.gov
    JUVÉDERM® ULTRA XC Other Phase PHASE4 Facial Rhytides ClinicalTrials.gov
    A gel of hyaluronic acid (concentration of 20 mg/mL) Other Phase PHASE4 Nasolabial Folds ClinicalTrials.gov
    Hyaluronic acid gel (24 mg/mL) with 0.3% lidocaine Other Phase PHASE4 Nasolabial Folds ClinicalTrials.gov
    Restylane-L® Other Approved Lip Volume Enhancement ClinicalTrials.gov
    Juvéderm® Volbella with Lidocaine Other Approved Lip Volume Enhancement ClinicalTrials.gov
    bimatoprost 0.03% Other Phase PHASE4 Eyelash Hypotrichosis ClinicalTrials.gov
    on-label facial injection Other Approved Facial Photodamage ClinicalTrials.gov
    Eluxadoline Other Phase PHASE4 Irritable Bowel Syndrome With Diarrhea ClinicalTrials.gov
    Intravitreal anti-VEGF injection Other Phase PHASE4 Diabetic Macular Edema ClinicalTrials.gov
    Dexamethasone intravitreal implant (0.7 mg) Other Phase PHASE4 Diabetic Macular Edema ClinicalTrials.gov
    0.9% saline solution Other Phase PHASE2 Skin Quality ClinicalTrials.gov
    Topical anesthesia Other Phase PHASE2 Skin Quality ClinicalTrials.gov
    Hyper-Diluted Botox Other Phase PHASE2 Skin Quality ClinicalTrials.gov
    Solifenacin Other Phase PHASE2 Dementia of Alzheimer's Type ClinicalTrials.gov
    Donepezil Other Phase PHASE2 Dementia of Alzheimer's Type ClinicalTrials.gov
    Dasabuvir Other Preclinical Chronic Hepatitis C ClinicalTrials.gov
    Paritaprevir/ritonavir/ombitasvir Other Preclinical Chronic Hepatitis C ClinicalTrials.gov
    AGN-223575 vehicle ophthalmic solution Other Phase PHASE2 Dry Eye Syndromes ClinicalTrials.gov
    AGN-223575 ophthalmic solution Other Phase PHASE2 Dry Eye Syndromes ClinicalTrials.gov
    VOLBELLA® with lidocaine Other Approved Infra-orbital Skin Depressions ClinicalTrials.gov
    carboxymethylcellulose sodium based new eye drop formulation Other Phase PHASE3 Bilateral LASIK Surgery ClinicalTrials.gov
    carboxymethylcellulose sodium based eye drop solution Other Phase PHASE3 Contact Lens Lubrication ClinicalTrials.gov
    carboxymethylcellulose based eye drop formula Other Phase PHASE3 Contact Lens Lubrication ClinicalTrials.gov
    botulinum toxin Type A (12 U) Other Phase PHASE3 Lateral Canthus Rhytides ClinicalTrials.gov
    botulinum toxin Type A (24 U) Other Phase PHASE3 Lateral Canthus Rhytides ClinicalTrials.gov
    Crosslinked hyaluronic acid dermal filler Other Approved Moderate to Severe Nasolabial Folds ClinicalTrials.gov
    Carboxymethylcellulose Based Lubricant Eye Drops Other Phase PHASE3 Dry Eye Syndromes ClinicalTrials.gov
    Carboxymethylcellulose Based Preservative-Free Lubricant Eye Drops Other Phase PHASE3 Dry Eye Syndromes ClinicalTrials.gov
    Carboxymethylcellulose Based Eye Drop Formulation B Other Phase PHASE3 Dry Eye Syndromes ClinicalTrials.gov
    Carboxymethylcellulose Based Eye Drop Formulation A Other Phase PHASE3 Dry Eye Syndromes ClinicalTrials.gov
    AGN-150998 Other Phase PHASE2 Age-related Macular Degeneration ClinicalTrials.gov
    carboxymethylcellulose sodium based New Eye Drop Formulation 2 Other Phase PHASE3 Dry Eye Syndromes ClinicalTrials.gov
    carboxymethylcellulose sodium based New Eye Drop Formulation 1 Other Phase PHASE3 Dry Eye Syndromes ClinicalTrials.gov
    Olopatadine Other Phase PHASE3 Conjunctivitis, Allergic ClinicalTrials.gov
    Vehicle to AGN-229666 Other Phase PHASE3 Conjunctivitis, Allergic ClinicalTrials.gov
    Bimatoprost 0.03% Formulation B Ophthalmic Solution Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    0.03% Bimatoprost Ophthalmic Solution and 0.5% Timolol Ophthalmic Solution Other Approved Open-angle Glaucoma ClinicalTrials.gov
    0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution Other Approved Open-angle Glaucoma ClinicalTrials.gov
    carboxymethylcellulose-based lubricant eye drops Other Phase PHASE4 Dry Eye Syndromes ClinicalTrials.gov
    Anti-VEGF Other Preclinical Retinal Vein Occlusion ClinicalTrials.gov
    Prostaglandin Analogue -Containing IOP-Lowering Therapy Drug Preclinical Glaucoma, Open-Angle ClinicalTrials.gov
    latanoprost 0.005% ophthalmic solution Other Phase PHASE4 Glaucoma, Open-Angle ClinicalTrials.gov
    bimatoprost 0.03%/timolol 0.5% combination ophthalmic solution Other Phase PHASE4 Glaucoma, Open-Angle ClinicalTrials.gov
    Bimatoprost Ophthalmic Solution Other Preclinical Glaucoma, Primary Open Angle ClinicalTrials.gov
    dexamethasone 700 ug intravitreal implant Other Preclinical Macular Edema ClinicalTrials.gov
    400 µg Brimonidine Implant Other Phase PHASE2 Geographic Atrophy ClinicalTrials.gov
    solifenacin placebo Other Phase PHASE3 Overactive Bladder ClinicalTrials.gov
    Botox placebo (normal saline) Other Phase PHASE3 Overactive Bladder ClinicalTrials.gov
    latanoprost 0.005% Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    timolol maleate 0.5% Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    Fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    bimatoprost eye drops Other Phase PHASE2 Glaucoma ClinicalTrials.gov
    bimatoprost 0.03% ophthalmic solution; hypromellose 0.2% eyedrops Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution; bimatoprost 0.03% ophthalmic solution Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    fixed combination of dorzolamide hydrochloride timolol maleate ophthalmic solution Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    Laser Photocoagulation Other Phase PHASE2 Diabetic Macular Edema ClinicalTrials.gov
    travoprost 0.004% eye drops Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    Ulipristal acetate (UPA) Other Phase PHASE3 Leiomyoma ClinicalTrials.gov
    Botulinum Toxin Type A 200U Other Phase PHASE3 Overactive Bladder ClinicalTrials.gov
    Botulinum Toxin Type A 300U Other Phase PHASE3 Overactive Bladder ClinicalTrials.gov
    Injectable sodium deoxycholate with Triamcinolone acetate Other Phase PHASE4 Adiposity ClinicalTrials.gov
    Injectable sodium deoxycholate Other Phase PHASE4 Adiposity ClinicalTrials.gov
    Control Other Approved Moderate to Severe Nasolabial Folds ClinicalTrials.gov
    JUVEDERM VOLIFT® XC Other Approved Moderate to Severe Nasolabial Folds ClinicalTrials.gov
    Ketamine Other Phase PHASE1 Human Abuse Potential ClinicalTrials.gov
    Rapastinel Other Phase PHASE1 Human Abuse Potential ClinicalTrials.gov
    Eye wash Other Approved Dry Eye ClinicalTrials.gov
    injection of NaCl 0.9% Other Phase PHASE3 COMPARISON BETWEEN GROUP TREATED WITH BOTULINUM TOXIN AND PLACEBO ClinicalTrials.gov
    Skin Imaging Other Approved Skin Care ClinicalTrials.gov
    Sunscreen Other Approved Skin Care ClinicalTrials.gov
    Moisturizing lotion Other Approved Skin Care ClinicalTrials.gov
    Facial cleanser Other Approved Skin Care ClinicalTrials.gov
    Retinol Complex 0.5 Other Approved Skin Care ClinicalTrials.gov
    Optive® Fusion + Optive® Gel Drop Other Approved Dry Eye ClinicalTrials.gov
    Botulinum Toxin commonly known as BOTOX® Other Phase PHASE3 Stroke With Hemiparesis ClinicalTrials.gov
    Dexamethasone pellet Other Phase PHASE4 Uveitis, Intermediate ClinicalTrials.gov
    Test product (B) Exemestane Other Phase PHASE1 Healthy ClinicalTrials.gov
    Reference product (A) Aromasin (Exemestane) Other Phase PHASE1 Healthy ClinicalTrials.gov
    bimatoprost solution 0.03% Other Phase PHASE3 Eyelash Hypotrichosis ClinicalTrials.gov
    Clobex TM 0.05% Lotion, single exposure Other Phase PHASE1 Healthy ClinicalTrials.gov
    Clobetasol Propionate 0.05% lotion, single exposure Other Phase PHASE1 Healthy ClinicalTrials.gov
    Clobex TM (Clobetasol) 0.05% Lotion, single exposure Other Phase PHASE1 Healthy ClinicalTrials.gov
    Ketamine Matched Placebo Other Phase PHASE1 Driving Performance ClinicalTrials.gov
    Alprazolam Matched Placebo Other Phase PHASE1 Driving Performance ClinicalTrials.gov
    Rapastinel Matched Placebo Other Phase PHASE1 Driving Performance ClinicalTrials.gov
    Alprazolam Other Phase PHASE1 Driving Performance ClinicalTrials.gov
    Vortioxetine Other Phase PHASE3 Depressive Disorder, Major ClinicalTrials.gov
    Relamorelin Other Phase PHASE2 Diabetes Mellitus ClinicalTrials.gov
    Eluxadoline 100 mg Other Phase PHASE2 Fecal Incontinence ClinicalTrials.gov
    Towel Other Phase PHASE3 Rosacea ClinicalTrials.gov
    Cleanser Other Phase PHASE3 Rosacea ClinicalTrials.gov
    Vehicle Foam Other Phase PHASE3 Rosacea ClinicalTrials.gov
    Finacea® (Azelaic Acid) Foam Other Phase PHASE3 Rosacea ClinicalTrials.gov
    Generic Azelaic Acid Foam Other Phase PHASE3 Rosacea ClinicalTrials.gov
    JUVÉDERM VOLUMA® XC injectable gel with needle Other Approved Age-related Volume Deficit in the Mid-face ClinicalTrials.gov
    JUVÉDERM VOLUMA® XC injectable gel with cannula Other Approved Age-related Volume Deficit in the Mid-face ClinicalTrials.gov
    Usual Care Other Phase PHASE3 Migraine, With or Without Aura ClinicalTrials.gov
    silk surgical scaffold Other Approved Mastopexy ClinicalTrials.gov
    Vehicle to AGN-199201 Other Phase PHASE3 Erythema ClinicalTrials.gov
    Oxymetazoline HCL Cream 1.0% Other Phase PHASE3 Erythema ClinicalTrials.gov
    AGN-199201 Dose C Other Phase PHASE2 Rosacea ClinicalTrials.gov
    AGN-199201 Dose B Other Phase PHASE2 Rosacea ClinicalTrials.gov
    AGN-199201 Dose A Other Phase PHASE2 Rosacea ClinicalTrials.gov
    AGN-199201 Formulation C Other Phase PHASE1 Rosacea ClinicalTrials.gov
    AGN-199201 Formulation B Other Phase PHASE1 Rosacea ClinicalTrials.gov
    AGN-199201 Formulation A Other Phase PHASE1 Rosacea ClinicalTrials.gov
    Rapastinel (225 mg/450 mg IV administration) Other Phase PHASE2 Major Depressive Disorder ClinicalTrials.gov
    Symbicort® (Budesonide/Formoterol Fumarate Dihydrate) Other Phase PHASE3 Asthma ClinicalTrials.gov
    Generic Budesonide/Formoterol Fumarate Dihydrate Other Phase PHASE3 Asthma ClinicalTrials.gov
    ABBV-075 Other Phase PHASE1 Cancer ClinicalTrials.gov
    extended intervention Other Approved Cross-Sectional Study ClinicalTrials.gov
    basic intervention Other Approved Cross-Sectional Study ClinicalTrials.gov
    Placebo Tablet Other Phase PHASE3 Diarrhea ClinicalTrials.gov
    Xifaxan® Other Phase PHASE3 Diarrhea ClinicalTrials.gov
    Rifaximin Other Phase PHASE3 Diarrhea ClinicalTrials.gov
    Zyclara® Other Phase PHASE3 Actinic Keratosis ClinicalTrials.gov
    Imiquimod Other Phase PHASE3 Actinic Keratosis ClinicalTrials.gov
    AGN-214868 Placebo (Vehicle) Other Phase PHASE2 Neuralgia, Postherpetic ClinicalTrials.gov
    Nabumetone 750 mg tablets, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Generic Ingenol Mebutate Other Phase PHASE3 ACTINIC KERATOSIS ClinicalTrials.gov
    Ingenol Mebutate (Picato®) Other Phase PHASE3 ACTINIC KERATOSIS ClinicalTrials.gov
    OnabotulinumtoxinA 50 UNT [Botox Cosmetic] Other Phase PHASE4 Aging ClinicalTrials.gov
    clindamycin phosphate vaginal cream 2% Other Phase PHASE3 BACTERIAL VAGINOSIS ClinicalTrials.gov
    Intranasal Tear Neurostimulator Other Approved Dry Eye Syndromes ClinicalTrials.gov
    Endura, Refresh artificial tears Other Approved Dry Eye ClinicalTrials.gov
    Cyclosporin 0.05% emulsion Other Approved Dry Eye ClinicalTrials.gov
    Placebo-matching Rapastinel Other Phase PHASE3 Depressive Disorder, Major ClinicalTrials.gov
    Botulinum toxin A Other Phase PHASE4 Cervical Dystonia ClinicalTrials.gov
    bimatoprost 10 µg generation 1 Other Phase PHASE1 Open-Angle Glaucoma ClinicalTrials.gov
    bimatoprost 15 µg generation 1 Other Phase PHASE1 Open-Angle Glaucoma ClinicalTrials.gov
    bimatoprost 6 µg generation 2 Other Phase PHASE1 Open-Angle Glaucoma ClinicalTrials.gov
    bimatoprost 10 µg generation 2 Other Phase PHASE1 Open-Angle Glaucoma ClinicalTrials.gov
    bimatoprost 15 µg generation 2 Other Phase PHASE1 Open-Angle Glaucoma ClinicalTrials.gov
    bimatoprost 20 µg generation 2 Other Phase PHASE1 Open-Angle Glaucoma ClinicalTrials.gov
    Lytera Other Approved Photoaging ClinicalTrials.gov
    Basic Skin Care Regimen Other Approved Photoaging ClinicalTrials.gov
    Laser Therapy Drug Approved Photoaging ClinicalTrials.gov
    Optive Other Phase PHASE3 Dry Eye Syndromes ClinicalTrials.gov
    Optive Advanced Other Phase PHASE3 Dry Eye Syndromes ClinicalTrials.gov
    Omega 3 Other Phase PHASE3 Dry Eye Syndromes ClinicalTrials.gov
    Clindamycin/benzoyl peroxide gel Other Phase PHASE3 Acne Vulgaris ClinicalTrials.gov
    Onexton Other Phase PHASE3 Acne Vulgaris ClinicalTrials.gov
    Pimecrolimus Cream, 1% Other Phase PHASE3 Atopic Dermatitis ClinicalTrials.gov
    Pimecrolimus Cream 1% (Valeant) Other Phase PHASE3 Atopic Dermatitis ClinicalTrials.gov
    Placebo/Vehicle cream Other Phase PHASE3 Moderate to Severe Papulopustular Rosacea ClinicalTrials.gov
    Ivermectin Cream, 1% Other Phase PHASE3 Moderate to Severe Papulopustular Rosacea ClinicalTrials.gov
    Finacea Other Phase PHASE3 Rosacea ClinicalTrials.gov
    Azelaic acid Other Phase PHASE3 Rosacea ClinicalTrials.gov
    Timolol Vehicle (placebo) Other Phase PHASE3 Glaucoma, Open-Angle ClinicalTrials.gov
    Sham: Applicator Without Needle Other Phase PHASE3 Glaucoma, Open-Angle ClinicalTrials.gov
    Active Comparator: Timolol 0.5% Other Phase PHASE3 Glaucoma, Open-Angle ClinicalTrials.gov
    Tazarotene (Actavis) Other Phase PHASE3 Acne Vulgaris ClinicalTrials.gov
    Tazarotene (Fabior™) Other Phase PHASE3 Acne Vulgaris ClinicalTrials.gov
    placebo gel Other Phase PHASE3 Acne ClinicalTrials.gov
    Adapalene and Benzoyl Peroxide Gel Other Phase PHASE3 Acne ClinicalTrials.gov
    Epiduo® Forte Gel Other Phase PHASE3 Acne ClinicalTrials.gov
    Euflexxa IA injection Other Approved Osteoarthritis ClinicalTrials.gov
    Hyaluronate Injectable Viscosupplement Other Approved Osteoarthritis ClinicalTrials.gov
    Diclofenac epolamine Other Phase PHASE3 Ankle Sprain ClinicalTrials.gov
    Anatomically shaped, silicone-filled breast implants with low projection or extra-full projection Other Approved Breast Augmentation ClinicalTrials.gov
    Avinza (morphine sulfate sustained-release) capsules Other Phase PHASE4 Healthy ClinicalTrials.gov
    KADIAN (morphine sulfate sustained-release) capsules Other Phase PHASE4 Healthy ClinicalTrials.gov
    KADIAN Capsule + alcohol (under fed conditions) Other Phase PHASE1 Healthy ClinicalTrials.gov
    morphine sulfate IR oral solution + water Other Phase PHASE1 Healthy ClinicalTrials.gov
    KADIAN Capsule + water (under fasting conditions) Other Phase PHASE1 Healthy ClinicalTrials.gov
    KADIAN Capsule + alcohol (under fasting conditions) Other Phase PHASE1 Healthy ClinicalTrials.gov
    Radiotherapy Drug Phase PHASE1 Non-small Cell Lung Cancer Stage III ClinicalTrials.gov
    Placebo for Veliparib Other Phase PHASE1 Non-small Cell Lung Cancer Stage III ClinicalTrials.gov
    Pancrelipase Other Phase PHASE2 Pancreatic Cancer ClinicalTrials.gov
    TrueTear Other Approved Cataract ClinicalTrials.gov
    Mometasone nasal spray Other Phase PHASE3 Seasonal Allergic Rhinitis ClinicalTrials.gov
    Refresh Endura Other Phase PHASE4 Primary Sjogren Syndrome ClinicalTrials.gov
    Ceftazidime-avibactam Other Preclinical Bacterial Infections ClinicalTrials.gov
    ZELTIQ thermoelectric device Device Approved Subcutaneous Fat ClinicalTrials.gov
    Thermalon Dry Eye Compress Other Approved Meibomian Glands ClinicalTrials.gov
    TrueTear™ Other Approved Meibomian Glands ClinicalTrials.gov
    Telemedicine follow-up visit Other Preclinical Cervical Dystonia ClinicalTrials.gov
    Bevacizumab Injectable Product Other Phase PHASE4 Diabetic Macular Edema ClinicalTrials.gov
    Botulinum Toxin Type A - OnabotulinumtoxinA Other Approved Post-stroke Shoulder Pain and Spasticity ClinicalTrials.gov
    Phacoemulsification Other Preclinical Glaucoma ClinicalTrials.gov
    XEN Group Other Preclinical Glaucoma ClinicalTrials.gov
    adalimumab (ADA) Other Phase PHASE4 Psoriatic Arthritis ClinicalTrials.gov
    methotrexate (MTX) Other Phase PHASE4 Psoriatic Arthritis ClinicalTrials.gov
    Bacteriostatic normal saline Other Approved Herpes Labialis ClinicalTrials.gov
    AGN-190584 Vehicle Other Phase PHASE2 Presbyopia ClinicalTrials.gov
    AGN-190584 ophthalmic solution Other Phase PHASE2 Presbyopia ClinicalTrials.gov
    AGN-199201 ophthalmic solution Other Phase PHASE2 Presbyopia ClinicalTrials.gov
    AGN-199201 + AGN-190584 Combination Other Phase PHASE2 Presbyopia ClinicalTrials.gov
    No-treatment control Drug Approved Nose Enhancement ClinicalTrials.gov
    JUVÉDERM® VOLUMA® with Lidocaine Other Approved Nose Enhancement ClinicalTrials.gov
    Juvéderm® VOLUMA™ with Lidocaine Other Phase PHASE4 Contour ClinicalTrials.gov
    BELKYRA® Other Phase PHASE4 Contour ClinicalTrials.gov
    ABT-165 Other Phase PHASE2 Cancer ClinicalTrials.gov
    Fluorouracil - infusion Other Phase PHASE2 Cancer ClinicalTrials.gov
    Fluorouracil - bolus Other Phase PHASE2 Cancer ClinicalTrials.gov
    TrueTear™ Application Other Approved Dry Eye Syndromes ClinicalTrials.gov
    Galcanezumab Other Phase PHASE1 Migraine ClinicalTrials.gov
    Erenumab Other Phase PHASE1 Migraine ClinicalTrials.gov
    intravitreal bevacizumab Other Phase PHASE2 Diabetic Macular Edema ClinicalTrials.gov
    CoolSculpting® System Other Approved Body Fat Disorder ClinicalTrials.gov
    Deoxycholic Acid Other Phase PHASE4 Brassiere Strap Fat (BSF) ClinicalTrials.gov
    Refresh Tears 0.5% Lubricant Eye Drops Other Phase PHASE2 Congenital Hereditary Endothelial Dystrophy of Cornea ClinicalTrials.gov
    Nepafenac 0.1% Oph Susp Other Phase PHASE2 Congenital Hereditary Endothelial Dystrophy of Cornea ClinicalTrials.gov
    Standard of Care (SOC) Migraine Preventive Medication Drug Phase PHASE3 Episodic Migraine ClinicalTrials.gov
    Juvéderm® VOLIFT™ with Lidocaine Other Phase PHASE4 Lip Augmentation ClinicalTrials.gov
    Intranasal Tear Neurostimulator (ITN) [TrueTear®] Other Approved Dry Eye Syndromes ClinicalTrials.gov
    Juvederm® VOLITE Other Approved Healthy Adults ClinicalTrials.gov
    Placebos Other Phase PHASE4 None (i.e. Healthy Volunteers) ClinicalTrials.gov
    Levomilnacipran Other Phase PHASE4 None (i.e. Healthy Volunteers) ClinicalTrials.gov
    Ceftaroline Fosamil Other Phase PHASE1 Hematogenously Acquired Staphylococcus Aureus Osteomyelitis ClinicalTrials.gov
    JUVÉDERM VOLBELLA® XC injectable gel Other Phase PHASE3 Infraorbital Hollowing ClinicalTrials.gov
    XEN45 gel stent implantation Other Approved Glaucoma ClinicalTrials.gov
    Ultrasound Other Approved Spasticity ClinicalTrials.gov
    Electrical stimulation Other Approved Spasticity ClinicalTrials.gov
    Relamorelin 10 μg Other Phase PHASE3 Gastroparesis ClinicalTrials.gov
    Pilocarpine HCl Ophthalmic Solution Other Phase PHASE3 Presbyopia ClinicalTrials.gov
    Sham Selective Laser Trabeculoplasty Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    Selective Laser Trabeculoplasty Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    Sham Bimatoprost SR Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    Topical Product C Other Approved Pigmentation ClinicalTrials.gov
    Topical Product B Other Approved Pigmentation ClinicalTrials.gov
    Topical Product A Other Approved Pigmentation ClinicalTrials.gov
    Cenicriviroc (CVC) Other Phase PHASE2 Covid19 ClinicalTrials.gov
    Androderm® Other Phase PHASE4 Hypogonadism ClinicalTrials.gov
    XEN-45 Gel Stent Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    EARFOLD® Other Phase PHASE4 Prominent Ears ClinicalTrials.gov
    Juvéderm® VOLIFT with Lidocaine Other Phase PHASE4 Skin Depressions ClinicalTrials.gov
    Cenicriviroc Mesylate (CVC) Other Phase PHASE2 HIV Infections ClinicalTrials.gov
    VOLUX XC Other Phase PHASE3 Jawline Definition ClinicalTrials.gov
    Atogepant 30 mg Other Phase PHASE3 Chronic Migraine ClinicalTrials.gov
    JUVÉDERM VOLUX® Other Preclinical Chin Retrusion ClinicalTrials.gov
    Pilocarpine HCl Other Phase PHASE3 Presbyopia ClinicalTrials.gov
    Normal saline pyloric injection Other Phase PHASE4 Bariatric Surgery ClinicalTrials.gov
    Botulinum toxin pyloroplasty Other Phase PHASE4 Bariatric Surgery ClinicalTrials.gov
    BOTOX® purified neurotoxin complex Other Phase PHASE2 Platysma Prominence ClinicalTrials.gov
    XEN45 Other Phase PHASE3 Glaucoma ClinicalTrials.gov
    Placebo arm Other Phase PHASE4 Bruxism ClinicalTrials.gov
    TrueTear Intranasal Tear Neurostimulator Other Approved Dry Eye Syndromes ClinicalTrials.gov
    Metronidazole Gel Other Phase PHASE4 Vaginosis, Bacterial ClinicalTrials.gov
    SkinMedica Other Phase PHASE4 Facial Rhytides, Skin Folds, Loss of Volume and Skin Quality ClinicalTrials.gov
    BOTOX Cosmetic® Other Phase PHASE4 Facial Rhytides, Skin Folds, Loss of Volume and Skin Quality ClinicalTrials.gov
    JUVÉDERM® Other Phase PHASE4 Facial Rhytides, Skin Folds, Loss of Volume and Skin Quality ClinicalTrials.gov
    Reminyl 4 mg Tablet, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    Galantamine 4 mg Tablet, single dose Other Phase PHASE1 Healthy ClinicalTrials.gov
    XEN Glaucoma Stent Other Preclinical Refractory Glaucoma ClinicalTrials.gov
    Levothyroxine Other Phase PHASE2 Hypothyroidism ClinicalTrials.gov
    Armour® Thyroid Other Phase PHASE2 Hypothyroidism ClinicalTrials.gov
    Corneal topography: Pentacam Other Approved Glaucoma, Open-Angle ClinicalTrials.gov
    Corneal topography: OPD-Scan Other Approved Glaucoma, Open-Angle ClinicalTrials.gov
    HArmonyCa Injectable Gel Other Phase PHASE4 Soft Tissue Augmentation ClinicalTrials.gov
    VOLBELLA with Lidocaine Other Phase PHASE3 Infraorbital Hollowing ClinicalTrials.gov
    Botox Cosmetic Injectable Product Other Phase PHASE2 Dermatological Non-Disease ClinicalTrials.gov
    New Emulsion, Optive, Soothe Other Approved Dry Eye Syndrome ClinicalTrials.gov
    Soothe, New Emulsion, Optive Other Approved Dry Eye Syndrome ClinicalTrials.gov
    Optive, Soothe, New Emulsion Other Approved Dry Eye Syndrome ClinicalTrials.gov
    Formulation C: OnabotulinumtoxinA Other Phase PHASE2 Glabellar Lines ClinicalTrials.gov
    Formulation B: OnabotulinumtoxinA Other Phase PHASE2 Glabellar Lines ClinicalTrials.gov
    Formulation A: OnabotulinumtoxinA Other Phase PHASE2 Glabellar Lines ClinicalTrials.gov
    OnabotulinumtoxinA X Other Phase PHASE2 Forehead Lines ClinicalTrials.gov
    Manufactured Anti-BCMA CAR-T cells Other Phase PHASE1 Refractory Multiple Myeloma ClinicalTrials.gov
    BOTOX ® 200 Unités Other Phase PHASE3 Essential Head Tremor ClinicalTrials.gov
    New formulation adalimumab Other Phase PHASE2 Rheumatoid Arthritis ClinicalTrials.gov
    ABT-126 Other Phase PHASE2 Alzheimer's Disease ClinicalTrials.gov
    Ritonavir Other Phase PHASE2 Hepatitis C ClinicalTrials.gov
    ABT-450 Other Phase PHASE2 Hepatitis C ClinicalTrials.gov
    Peginterferon alpha-2a Other Phase PHASE2 Hepatitis C ClinicalTrials.gov
    Blood sample collection only Other Phase PHASE2 HCV Infection ClinicalTrials.gov
    J-tube Other Phase PHASE3 Advanced Parkinson's Disease ClinicalTrials.gov
    PEG tube Other Phase PHASE3 Advanced Parkinson's Disease ClinicalTrials.gov
    CADD-Legacy® 1400 ambulatory infusion pump Other Phase PHASE3 Advanced Parkinson's Disease ClinicalTrials.gov
    Placebo (PBO) oral capsules Other Phase PHASE3 Advanced Parkinson's Disease ClinicalTrials.gov
    Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets Other Phase PHASE3 Advanced Parkinson's Disease ClinicalTrials.gov
    Levodopa carbidopa intestinal gel (LCIG) Other Phase PHASE3 Advanced Parkinson's Disease ClinicalTrials.gov
    Levodopa-carbidopa intestinal gel Other Phase PHASE3 Advanced Parkinson's Disease ClinicalTrials.gov
    ABT-267 Other Phase PHASE2 Chronic Hepatitis C ClinicalTrials.gov
    Immediate post-screening treatment education Drug Approved HIV ClinicalTrials.gov
    ABT-530 Other Phase PHASE1 Hepatic Impairment ClinicalTrials.gov
    ABT-493 Other Phase PHASE1 Hepatic Impairment ClinicalTrials.gov
    biological treatment Drug Preclinical Psoriasis ClinicalTrials.gov
    ABBV-257 Other Phase PHASE1 Rheumatoid Arthritis ClinicalTrials.gov
    jejunal extension tube (J-tube) Other Phase PHASE4 Advanced Idiopathic Parkinson's Disease ClinicalTrials.gov
    percutaneous endoscopic gastrostomy tube (PEG tube) Other Phase PHASE4 Advanced Idiopathic Parkinson's Disease ClinicalTrials.gov
    Levodopa-carbidopa intestinal gel (LCIG) Other Phase PHASE4 Advanced Idiopathic Parkinson's Disease ClinicalTrials.gov
    DSM265 25% SDD powder for suspension Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    DSM265 50% SDD granules Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Technetium labelled glucosamine Other Preclinical Rheumatoid Arthritis ClinicalTrials.gov
    BI 655066 (low medium i.v. dose) Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    Placebo, s.c. Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    BI 655066 (high i.v. dose) Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    BI 655066 (low s.c. dose) Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    BI 655066 (very low i.v. dose) Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    BI 655066 (high medium i.v. dose) Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    BI 655066 (low i.v. dose) Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    BI 655066 (high s.c. dose) Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    Placebo, i.v. Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    BI 655066 (very high i.v. dose) Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    sofosbuvir (SOF) Other Phase PHASE3 Chronic Hepatitis C Virus (HCV Infection Genotype 1) ClinicalTrials.gov
    ombitasvir/paritaprevir/ritonavir, dasabuvir Other Phase PHASE3 Chronic Hepatitis C Virus (HCV Infection Genotype 1) ClinicalTrials.gov
    Adalimumab 40 MG/0.8 ML Subcutaneous Solution [HUMIRA] Other Approved Psoriasis ClinicalTrials.gov
    ABT-806 Other Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    ABT-555 Other Phase PHASE1 Multiple Sclerosis ClinicalTrials.gov
    PET/CT imaging Other Phase PHASE4 Ankylosing Spondyloarthritis ClinicalTrials.gov
    Matched Placebo - Sugar Pill Other Phase PHASE2 Alcohol Dependence ClinicalTrials.gov
    Hydroxychloroquine Other Phase PHASE2 Prostate Cancer ClinicalTrials.gov
    Abiraterone Other Phase PHASE2 Prostate Cancer ClinicalTrials.gov
    ABBV-838 Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Chama cha MamaToto Other Approved Pregnancy Related ClinicalTrials.gov
    ABBV-066 Other Phase PHASE1 Healthy ClinicalTrials.gov
    ombitasvir/paritaprevir/ritonavir and dasabuvir Other Phase PHASE3 Chronic Hepatitis C Infection ClinicalTrials.gov
    Placebo for ABT-981 Other Phase PHASE2 Erosive Hand Osteoarthritis ClinicalTrials.gov
    ABT-981 Other Phase PHASE2 Erosive Hand Osteoarthritis ClinicalTrials.gov
    Atrasentan placebo group Other Phase PHASE2 Chronic Kidney Disease ClinicalTrials.gov
    Atrasentan high dose group Other Phase PHASE2 Chronic Kidney Disease ClinicalTrials.gov
    Atrasentan low dose group Other Phase PHASE2 Chronic Kidney Disease ClinicalTrials.gov
    Metoprolol Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    Omeprazole Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    Warfarin Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    Caffeine Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    Placebo for ombitasvir/paritaprevir/ritonavir and dasabuvir Other Phase PHASE3 Hepatitis C Virus (HCV) ClinicalTrials.gov
    Ombitasvir/ABT-450/Ritonavir Other Phase PHASE2 Chronic Hepatitis C ClinicalTrials.gov
    ABBV-553 Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    Veliparib (ABT-888) Other Phase PHASE1 Breast Cancer ClinicalTrials.gov
    Tofacitinib Other Phase PHASE1 Rheumatoid Arthritis ClinicalTrials.gov
    radiation Other Phase PHASE1 Locally Advanced Rectal Cancer ClinicalTrials.gov
    capecitabine Other Phase PHASE1 Locally Advanced Rectal Cancer ClinicalTrials.gov
    ABT-348 and azacitidine Other Phase PHASE1 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    irinotecan (weekly schedule) Other Phase PHASE1 Solid Tumors ClinicalTrials.gov
    irinotecan (3-week schedule) Other Phase PHASE1 Solid Tumors ClinicalTrials.gov
    Placebo for ritonavir Other Phase PHASE1 HCV Infection ClinicalTrials.gov
    placebo for ABT-450 Other Phase PHASE1 HCV Infection ClinicalTrials.gov
    Matching Placebo Other Phase PHASE1 Major Depressive Disorder ClinicalTrials.gov
    ABT-308 Other Phase PHASE1 Asthma ClinicalTrials.gov
    ABT-288 Other Phase PHASE1 Schizophrenia ClinicalTrials.gov
    M200 (Volociximab), Carboplatin, Paclitaxel Other Phase PHASE1 Non-small Cell Lung Cancer ClinicalTrials.gov
    ABT-888 Other Phase PHASE1 Non-hematologic Malignancies ClinicalTrials.gov
    Fluvoxamine maleate Other Phase PHASE3 Obsessive Compulsive Disorder ClinicalTrials.gov
    Glecaprevir-pibrentasvir Other Phase PHASE4 Hepatitis C ClinicalTrials.gov
    Testosterone Gel 1.62% Other Phase PHASE1 Hypogonadism ClinicalTrials.gov
    Sofosbuvir Other Phase PHASE2 Chronic Hepatitis C Infection ClinicalTrials.gov
    ABT-767 Other Phase PHASE1 Fallopian Tube ClinicalTrials.gov
    FOS Other Approved Crohn Disease ClinicalTrials.gov
    ABT-450/ritonavir (r) Other Phase PHASE2 Chronic Hepatitis C ClinicalTrials.gov
    ABBV-221 Other Phase PHASE1 Head and Neck Squamous Cell Carcinoma ClinicalTrials.gov
    SC-007 Other Phase PHASE1 Colorectal Cancer (CRC) ClinicalTrials.gov
    Placebo for adalimumab Other Phase PHASE2 Crohn's Disease ClinicalTrials.gov
    ABT-450/ritonavir, ABT-267 Other Phase PHASE2 Chronic Hepatitis C Infection ClinicalTrials.gov
    pegylated liposomal doxorubicin Other Phase PHASE2 Ovarian Cancer ClinicalTrials.gov
    1.75 mg Atrasentan QD Other Phase PHASE2 Chronic Kidney Disease ClinicalTrials.gov
    0.75 mg Atrasentan QD Other Phase PHASE2 Chronic Kidney Disease ClinicalTrials.gov
    0.25 mg Atrasentan QD Other Phase PHASE2 Chronic Kidney Disease ClinicalTrials.gov
    Placebo for Atrasentan 0.2 mg/mL solution Other Phase PHASE2 Chronic Kidney Disease ClinicalTrials.gov
    etoposide/cisplatin Other Phase PHASE1 Solid Tumors ClinicalTrials.gov
    pegylated interferon alpha-2a (pegIFN) Other Phase PHASE2 Chronic Hepatitis C ClinicalTrials.gov
    ABT-450/r Other Phase PHASE2 Chronic Hepatitis C ClinicalTrials.gov
    Placebo for ABT-267 Other Phase PHASE2 Chronic Hepatitis C ClinicalTrials.gov
    Pegylated interferon (pegIFN) Other Phase PHASE2 Chronic Hepatitis C ClinicalTrials.gov
    Adalimumab delivered in Physiolis autoinjector Other Phase PHASE2 Rheumatoid Arthritis ClinicalTrials.gov
    Adalimumab delivered in current autoinjector Other Phase PHASE2 Rheumatoid Arthritis ClinicalTrials.gov
    Adalimumab delivered in Physiolis syringe Other Phase PHASE2 Rheumatoid Arthritis ClinicalTrials.gov
    Adalimumab delivered in current syringe Other Phase PHASE2 Rheumatoid Arthritis ClinicalTrials.gov
    Pegylated interferon Other Phase PHASE2 Chronic Hepatitis C Virus Infection ClinicalTrials.gov
    Placebo for ABT-333 Other Phase PHASE2 Chronic Hepatitis C Virus Infection ClinicalTrials.gov
    Atorvastatin Other Phase PHASE3 Coronary Artery Disease ClinicalTrials.gov
    ABT-335 Other Phase PHASE3 Coronary Artery Disease ClinicalTrials.gov
    Placebo to Leuprorelin Acetate Other Phase PHASE2 Endometriosis ClinicalTrials.gov
    Placebo to Elagolix Other Phase PHASE2 Endometriosis ClinicalTrials.gov
    Leuprorelin Acetate Depot Other Phase PHASE2 Endometriosis ClinicalTrials.gov
    Placebo to DMPA-SC Other Phase PHASE2 Endometriosis ClinicalTrials.gov
    Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) Other Phase PHASE2 Endometriosis ClinicalTrials.gov
    paritaprevir/ritonavir/ombitasvir + dasabuvir +/- ribavirin Other Phase PHASE4 Chronic Hepatitis C ClinicalTrials.gov
    Calcifediol Other Phase PHASE4 Secondary Hyperparathyroidism Due to Renal Causes ClinicalTrials.gov
    Fluorouracil infusion Other Phase PHASE2 Untreated Metastatic Colorectal Cancer ClinicalTrials.gov
    Modified FOLFIRI Other Phase PHASE2 Untreated Metastatic Colorectal Cancer ClinicalTrials.gov
    ABBV-176 Other Phase PHASE1 Advanced Solid Tumors Cancer ClinicalTrials.gov
    SC-005 Other Phase PHASE1 Breast Cancer ClinicalTrials.gov
    Rovalpituzumab tesirine Other Phase PHASE3 Small Cell Lung Cancer ClinicalTrials.gov
    ABBV-399 Other Phase PHASE1 Advanced Solid Tumors Cancer ClinicalTrials.gov
    ABBV-085 Other Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Atrasentan Other Phase PHASE3 Diabetic Nephropathy ClinicalTrials.gov
    Creon36™ Other Phase PHASE2 Chronic Pancreatitis ClinicalTrials.gov
    caremessage Other Approved Medication Adherence ClinicalTrials.gov
    SC-004 Other Phase PHASE1 Cancer ClinicalTrials.gov
    placebo for risankizumab Other Phase PHASE2 Psoriasis ClinicalTrials.gov
    Bendamustine Other Phase PHASE2 Follicular Lymphoma ClinicalTrials.gov
    lamivudine Other Preclinical HIV-1 Infection ClinicalTrials.gov
    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Drug Phase PHASE4 Axial Spondyloarthritis ClinicalTrials.gov
    PTV/r/OBV/DSV Other Phase PHASE4 Hepatitis Viruses ClinicalTrials.gov
    EXVIERA Other Phase PHASE4 HCV Coinfection ClinicalTrials.gov
    VEKIRAX Other Phase PHASE4 HCV Coinfection ClinicalTrials.gov
    ABT450r-ABT267-ABT333 +/- Ribavirin Other Phase PHASE4 Hepatitis C ClinicalTrials.gov
    Fecal calprotectin Other Approved Spondyloarthropathy ClinicalTrials.gov
    PROMETHEUS® IBD sgi Diagnostic™ Other Approved Spondyloarthropathy ClinicalTrials.gov
    colonoscopy Other Approved Spondyloarthropathy ClinicalTrials.gov
    Videocapsule endoscopy Other Approved Spondyloarthropathy ClinicalTrials.gov
    ABBV-8E12 Other Preclinical Primary Tauopathy Corticobasal Degeneration Syndrome (CBD) ClinicalTrials.gov
    Standard of Care (SOC) Physiotherapy Drug Preclinical Axial Spondyloarthritis ClinicalTrials.gov
    Active Supervised Training (AST) Other Preclinical Axial Spondyloarthritis ClinicalTrials.gov
    Patient support program Other Preclinical Chronic Hepatitis C ClinicalTrials.gov
    nivolumab Other Phase PHASE1 Non-Small Cell Lung Cancer ClinicalTrials.gov
    AbbVie Care 2.0 Other Preclinical Rheumatoid Arthritis ClinicalTrials.gov
    estradiol/norethindrone acetate (E2/NETA) Other Phase PHASE3 Endometriosis ClinicalTrials.gov
    pibrentasvir Other Preclinical Hepatitis C Virus Infection ClinicalTrials.gov
    glecaprevir Other Preclinical Hepatitis C Virus Infection ClinicalTrials.gov
    SC-006 Other Phase PHASE1 Colorectal Cancer ClinicalTrials.gov
    Ribavirin 200Mg Tablet Other Phase PHASE3 Hepatitis C ClinicalTrials.gov
    Glecaprevir/Pibrentasvir (G/P) 300mg/120mg Other Phase PHASE3 Hepatitis C ClinicalTrials.gov
    Skin Tape Stripping Other Approved Psoriasis ClinicalTrials.gov
    DSM265 25% SDD, 400 mg fasted Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    DSM265-TPGS 34% SDD, 400 mg fed Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    DSM265-TPGS 34% SDD, 400 mg fasted Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Pancreatic Enzyme Other Phase PHASE2 Short Bowel Syndrome ClinicalTrials.gov
    Risankizumab 180 mg SC Other Phase PHASE2 Crohn Disease ClinicalTrials.gov
    Risankizumab 600 mg IV Other Phase PHASE2 Crohn Disease ClinicalTrials.gov
    Lomustine Other Phase PHASE2 Glioblastoma ClinicalTrials.gov
    Depatuxizumab mafodotin Other Phase PHASE2 Glioblastoma ClinicalTrials.gov
    Prednisone Other Phase PHASE1 Lymphoma, Non-Hodgkin ClinicalTrials.gov
    Doxorubicin Other Phase PHASE1 Lymphoma, Non-Hodgkin ClinicalTrials.gov
    Obinutuzumab Other Phase PHASE1 Lymphoma, Non-Hodgkin ClinicalTrials.gov
    Placebo for Elagolix Other Phase PHASE3 Uterine Fibroids ClinicalTrials.gov
    Estradiol/Norethindrone Acetate Other Phase PHASE3 Uterine Fibroids ClinicalTrials.gov
    Placebo for Estradiol/Norethindrone Acetate Other Phase PHASE3 Uterine Fibroids ClinicalTrials.gov
    Intensity modulated radiation therapy Drug Phase PHASE1 Pancreatic Cancer ClinicalTrials.gov
    ABBV-428 Other Phase PHASE1 Advanced Solid Tumors Cancer ClinicalTrials.gov
    E2/NETA placebo Other Phase PHASE2 Heavy Uterine Bleeding ClinicalTrials.gov
    1 mg estradiol / 0.5 mg norethindrone acetate Other Phase PHASE2 Heavy Uterine Bleeding ClinicalTrials.gov
    0.5 mg estradiol / 0.1 mg norethindrone acetate Other Phase PHASE2 Heavy Uterine Bleeding ClinicalTrials.gov
    Elagolix placebo Other Phase PHASE2 Heavy Uterine Bleeding ClinicalTrials.gov
    Jejunal extension tube Other Phase PHASE3 Parkinson's Disease (PD) ClinicalTrials.gov
    Percutaneous endoscopic gastrostomy tube Other Phase PHASE3 Parkinson's Disease (PD) ClinicalTrials.gov
    CADD-Legacy ambulatory infusion pump Other Phase PHASE3 Parkinson's Disease (PD) ClinicalTrials.gov
    Optimized antiparkinsonian treatment Drug Phase PHASE3 Parkinson's Disease (PD) ClinicalTrials.gov
    Endoscopic balloon dilatation Other Phase PHASE4 Crohn Disease ClinicalTrials.gov
    Thiopurine Other Phase PHASE4 Crohn Disease ClinicalTrials.gov
    Adalimumab Injection Other Phase PHASE4 Crohn Disease ClinicalTrials.gov
    Liver vein catheterization Other Preclinical Hepatitis C ClinicalTrials.gov
    Galactose Elimination Capacity (GEC) Other Preclinical Hepatitis C ClinicalTrials.gov
    Functional Hepatic Nitrogen Clearance (FHNC) Other Preclinical Hepatitis C ClinicalTrials.gov
    Placebo to veliparib Other Phase PHASE3 Squamous Non-Small Cell Lung Cancer ClinicalTrials.gov
    ombitasvir, paritaprevir/r, dasabuvir Other Phase PHASE4 Hepatitis C, Chronic ClinicalTrials.gov
    ombitasvir, paritaprevir/r, dasabuvir + ribavirin Other Phase PHASE4 Hepatitis C, Chronic ClinicalTrials.gov
    placebo for rizankizumab Other Phase PHASE3 Psoriasis ClinicalTrials.gov
    Placebo solution for IV infusion on Day 15 Other Phase PHASE2 Progressive Supranuclear Palsy (PSP) ClinicalTrials.gov
    Venetoclax (RP2D) Other Phase PHASE1 Relapsed Small Cell Lung Cancer ClinicalTrials.gov
    Irinotecan 60 mg/m2 Other Phase PHASE1 Relapsed Small Cell Lung Cancer ClinicalTrials.gov
    Venetoclax 600 Other Phase PHASE1 Relapsed Small Cell Lung Cancer ClinicalTrials.gov
    Venetoclax 400 Other Phase PHASE1 Relapsed Small Cell Lung Cancer ClinicalTrials.gov
    Venetoclax 200 MG Other Phase PHASE1 Relapsed Small Cell Lung Cancer ClinicalTrials.gov
    Venetoclax 100 MG Other Phase PHASE1 Relapsed Small Cell Lung Cancer ClinicalTrials.gov
    Venetoclax 50 MG Other Phase PHASE1 Relapsed Small Cell Lung Cancer ClinicalTrials.gov
    Placebo solution for risankizumab Other Phase PHASE3 Psoriasis ClinicalTrials.gov
    No pancreatic enzyme replacement therapy Drug Preclinical Fibrosing Colonopathy ClinicalTrials.gov
    PERTZYE Other Preclinical Fibrosing Colonopathy ClinicalTrials.gov
    other non-sponsor pancreatic enzyme replacement therapy Drug Preclinical Fibrosing Colonopathy ClinicalTrials.gov
    ZENPEP Other Preclinical Fibrosing Colonopathy ClinicalTrials.gov
    CREON Other Preclinical Fibrosing Colonopathy ClinicalTrials.gov
    PANCREAZE Other Preclinical Fibrosing Colonopathy ClinicalTrials.gov
    ULTRESA Other Preclinical Fibrosing Colonopathy ClinicalTrials.gov
    ABBV-744 Other Phase PHASE1 Acute Myeloid Leukemia (AML) ClinicalTrials.gov
    rituximab / IDEC-C2B8 Other Phase PHASE1 Non-Hodgkin Lymphoma (NHL) ClinicalTrials.gov
    azacitadine Other Phase PHASE1 Non-Hodgkin Lymphoma (NHL) ClinicalTrials.gov
    Veliparib, tablet Other Phase PHASE1 Cancer - Ovarian ClinicalTrials.gov
    Veliparib, capsule Other Phase PHASE1 Cancer - Ovarian ClinicalTrials.gov
    Pneumococcal 13-valent conjugate vaccine (PCV-13) Other Phase PHASE2 Rheumatoid Arthritis ClinicalTrials.gov
    Lemzoparlimab Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    ABBV-CLS-7262 Other Phase PHASE1 Healthy ClinicalTrials.gov
    Placebo for venetoclax Other Phase PHASE3 Relapsed/Refractory Multiple Myeloma ClinicalTrials.gov
    Liposomal daunorubicin and cytarabine Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    ABBV-903 Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    AndroGel® Other Phase PHASE4 Hypogonadism ClinicalTrials.gov
    BOTOX Dose C Other Phase PHASE2 Ventral Hernia ClinicalTrials.gov
    BOTOX Dose B Other Phase PHASE2 Ventral Hernia ClinicalTrials.gov
    BOTOX Dose A Other Phase PHASE2 Ventral Hernia ClinicalTrials.gov
    Standard cytotherapy Drug Phase PHASE2 Adenocarcinoma ClinicalTrials.gov
    Ramucirumab Other Phase PHASE2 Adenocarcinoma ClinicalTrials.gov
    Bemarituzumab Other Phase PHASE2 Adenocarcinoma ClinicalTrials.gov
    Trastuzumab Other Phase PHASE2 Adenocarcinoma ClinicalTrials.gov
    Ophthalmic steroid ointment Other Phase PHASE3 Glioblastoma Multiforme ClinicalTrials.gov
    Cold compress Other Phase PHASE3 Glioblastoma Multiforme ClinicalTrials.gov
    Vasoconstrictor eye drops Other Phase PHASE3 Glioblastoma Multiforme ClinicalTrials.gov
    Steroid eye drops Other Phase PHASE3 Glioblastoma Multiforme ClinicalTrials.gov
    Placebo for elsubrutinib Other Phase PHASE2 Rheumatoid Arthritis (RA) ClinicalTrials.gov
    Elsubrutinib Other Phase PHASE2 Rheumatoid Arthritis (RA) ClinicalTrials.gov
    ABBV-321 Other Phase PHASE1 Advanced Solid Tumors Cancer ClinicalTrials.gov
    Placebo for ABBV-157 Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    ABBV-157 Other Phase PHASE1 Psoriasis ClinicalTrials.gov
    Autoinjector Other Phase PHASE3 Psoriasis ClinicalTrials.gov
    ABT-SLV187 Other Phase PHASE3 Advanced Parkinson's Disease ClinicalTrials.gov
    ABT-957 Other Phase PHASE1 Alzheimer's Disease ClinicalTrials.gov
    Placebo for ABT-957 Other Phase PHASE1 Alzheimer's Disease ClinicalTrials.gov
    OBV/PTV/r Other Phase PHASE2 Chronic Hepatitis C Virus Infection ClinicalTrials.gov
    Placebo for Ribavirin Other Phase PHASE3 Chronic Hepatitis C Infection ClinicalTrials.gov
    Placebo for ABT-450/r/ABT-267 Other Phase PHASE3 Chronic Hepatitis C Infection ClinicalTrials.gov
    secukinumab Other Phase PHASE3 Psoriasis ClinicalTrials.gov
    ABT-493 coformulated with ABT-530 Other Phase PHASE3 Hepatitis C Virus Infection ClinicalTrials.gov
    Progesterone Other Phase PHASE2 Heavy Uterine Bleeding ClinicalTrials.gov
    Estradiol Other Phase PHASE2 Heavy Uterine Bleeding ClinicalTrials.gov
    Placebo for ABT-493/ABT-530 Other Phase PHASE3 Chronic Hepatitis C Virus (HCV) Infection ClinicalTrials.gov
    Levodopa-carbidopa Immediate Release (LC-IR) Tablets Other Phase PHASE3 Advanced Parkinson's Disease ClinicalTrials.gov
    Percutaneous Endoscopic Gastrostomy with Jejunal Extension (PEG-J) Other Phase PHASE3 Advanced Parkinson's Disease ClinicalTrials.gov
    Placebo for ABBV-3373 Other Phase PHASE2 Rheumatoid Arthritis (RA) ClinicalTrials.gov
    ABBV-3373 Other Phase PHASE2 Rheumatoid Arthritis (RA) ClinicalTrials.gov
    blood drawing Other Approved Chronic Hepatitis C ClinicalTrials.gov
    Vinorelbine Other Preclinical Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation ClinicalTrials.gov
    ABBV-467 Other Phase PHASE1 Multiple Myeloma (MM) ClinicalTrials.gov
    Placebo for rovalpituzumab tesirine Other Phase PHASE3 Small Cell Lung Cancer ClinicalTrials.gov
    Placebo for dexamethasone Other Phase PHASE3 Small Cell Lung Cancer ClinicalTrials.gov
    Long- and intermediate- acting insulins Other Preclinical Diabetes ClinicalTrials.gov
    placebo for ustekinumab Other Phase PHASE3 Psoriasis ClinicalTrials.gov
    ustekinumab Other Phase PHASE3 Psoriasis ClinicalTrials.gov
    Daclatasvir Other Phase PHASE3 Chronic Hepatitis C ClinicalTrials.gov
    RBV Other Phase PHASE3 HCV ClinicalTrials.gov
    2 DAA Other Phase PHASE3 HCV ClinicalTrials.gov
    Darbepoetin alfa Other Phase PHASE4 Moderate to Severe Secondary Hyperparathyroidism ClinicalTrials.gov
    Placebo for ABBV-2B04 Other Phase PHASE1 CoronaVirus Disease-2019 (COVID-19) ClinicalTrials.gov
    ABBV-2B04 Other Phase PHASE1 CoronaVirus Disease-2019 (COVID-19) ClinicalTrials.gov
    Placebo for ABBV-47D11 Other Phase PHASE1 CoronaVirus Disease-2019 (COVID-19) ClinicalTrials.gov
    ABBV-47D11 Other Phase PHASE1 CoronaVirus Disease-2019 (COVID-19) ClinicalTrials.gov
    Ribavirin solution Other Phase PHASE2 Chronic Hepatitis C Infection ClinicalTrials.gov
    Dasabuvir mini tablet Other Phase PHASE2 Chronic Hepatitis C Infection ClinicalTrials.gov
    Ritonavir mini tablet Other Phase PHASE2 Chronic Hepatitis C Infection ClinicalTrials.gov
    Paritaprevir mini tablet Other Phase PHASE2 Chronic Hepatitis C Infection ClinicalTrials.gov
    Ombitasvir mini tablet Other Phase PHASE2 Chronic Hepatitis C Infection ClinicalTrials.gov
    Chemotherapy Drug Phase PHASE1 Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov
    Adalimumab 40 mg Other Phase PHASE2 Osteoarthritis, Knee ClinicalTrials.gov
    Mavyret Other Phase PHASE4 Chronic Kidney Disease ClinicalTrials.gov
    Viekira Pak ± ribavirin Other Phase PHASE4 Chronic Kidney Disease ClinicalTrials.gov
    AMG 176 Other Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    upadacitinib 15mg/day Other Phase PHASE3 Rheumatoid Arthritis ClinicalTrials.gov
    Placebo ABBV-0805 Other Phase PHASE1 Parkinson's Disease ClinicalTrials.gov
    ABBV-0805 Other Phase PHASE1 Parkinson's Disease ClinicalTrials.gov
    ABT-199 (Safety Expansion Cohort) Other Phase PHASE2 Chronic Lymphocytic Leukemia ClinicalTrials.gov
    ABT-199 (Main Cohort) Other Phase PHASE2 Chronic Lymphocytic Leukemia ClinicalTrials.gov
    Ravaglimab Other Phase PHASE2 Sjogren's Syndrome (SS) ClinicalTrials.gov
    Alvocidib Other Phase PHASE1 Acute Myeloid Leukemia (AML) ClinicalTrials.gov
    Sleep Headband Other Phase PHASE1 Atopic Dermatitis ClinicalTrials.gov
    Wrist Actigraphy Device Device Phase PHASE1 Atopic Dermatitis ClinicalTrials.gov
    Cariprazine 3.0 mg/day Other Phase PHASE2 Generalized Anxiety Disorder ClinicalTrials.gov
    Cariprazine 1.5 mg/day Other Phase PHASE2 Generalized Anxiety Disorder ClinicalTrials.gov
    Cariprazine 0.75 mg/day Other Phase PHASE2 Generalized Anxiety Disorder ClinicalTrials.gov
    ABT199 Other Phase PHASE2 Waldenstrom Macroglobulinemia ClinicalTrials.gov
    ABT-199 and Ibrutinib Combination Other Phase PHASE1 Lymphoma, Mantle-Cell ClinicalTrials.gov
    Matching Placebo for Upadacitinib Other Phase PHASE3 Crohn's Disease ClinicalTrials.gov
    placebo for ABBV-8E12 Other Phase PHASE2 Alzheimer's Disease ClinicalTrials.gov
    ABBV-184 Other Phase PHASE1 Acute Myeloid Leukemia (AML) ClinicalTrials.gov
    Tilavonemab Other Phase PHASE2 Alzheimer's Disease ClinicalTrials.gov
    Placebo for ABBV-990 Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    ABBV-990 Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Home titration Other Preclinical Parkinson Disease ClinicalTrials.gov
    Placebo for ABBV-951 Other Phase PHASE3 Parkinson's Disease (PD) ClinicalTrials.gov
    Levodopa/Carbidopa (LD/CD) Other Phase PHASE3 Parkinson's Disease (PD) ClinicalTrials.gov
    Placebo for Levodopa/Carbidopa (LD/CD) Other Phase PHASE3 Parkinson's Disease (PD) ClinicalTrials.gov
    Percutaneous Endoscopic Gastrostomy with jejunal extension tube (PEG-J) Other Phase PHASE3 Advanced Parkinson's Disease ClinicalTrials.gov
    Cedirogant Other Phase PHASE1 Hepatic Impairment ClinicalTrials.gov
    Comparator 2 Other Preclinical Psoriasis ClinicalTrials.gov
    Comparator 1 Other Preclinical Psoriasis ClinicalTrials.gov
    ABBV-621 Other Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    AndroGel 1.62% Other Phase PHASE4 Hypogonadism ClinicalTrials.gov
    Dinaciclib Other Phase PHASE1 Cancer - Acute Myeloid Leukemia ClinicalTrials.gov
    Navocaftor Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Galicaftor Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    ABBV-992 Other Phase PHASE1 B-cell Lymphoma ClinicalTrials.gov
    ABBV-623 Other Phase PHASE1 B-cell Lymphoma ClinicalTrials.gov
    ABBV-576 Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Tilsotolimod Other Phase PHASE1 Advanced Solid Tumors Cancer ClinicalTrials.gov
    Approved DEX PS DDS Applicator Other Phase PHASE3 Macular Edema ClinicalTrials.gov
    Updated DEX PS DDS Applicator Other Phase PHASE3 Macular Edema ClinicalTrials.gov
    Topical Corticosteroids (TCS) Other Phase PHASE3 Atopic Dermatitis ClinicalTrials.gov
    ABBV-154 Dose Formulation B Other Phase PHASE1 ABBV-154 ClinicalTrials.gov
    ABBV-154 Dose Formulation A Other Phase PHASE1 ABBV-154 ClinicalTrials.gov
    Ravagalimab 300 mg Other Phase PHASE2 Ulcerative Colitis (UC) ClinicalTrials.gov
    Ravagalimab 600 mg Other Phase PHASE2 Ulcerative Colitis (UC) ClinicalTrials.gov
    ABBV-552 Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Risankizumab Dose B Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Risankizumab Dose A Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Glecaprevir + Pibrentasvir Pediatric Formulation Other Phase PHASE2 Hepatitis C Virus (HCV) ClinicalTrials.gov
    Glecaprevir/Pibrentasvir Adult Formulation Other Phase PHASE2 Hepatitis C Virus (HCV) ClinicalTrials.gov
    Placebo for ABT-414 Other Phase PHASE3 Glioblastoma ClinicalTrials.gov
    Posaconazole Other Phase PHASE1 Acute Myelogenous Leukemia ClinicalTrials.gov
    Ubrogepant 100 mg Other Phase PHASE3 Migraine ClinicalTrials.gov
    Therapy Education Drug Phase PHASE4 Ulcerative Colitis ClinicalTrials.gov
    e-Monitoring Other Phase PHASE4 Ulcerative Colitis ClinicalTrials.gov
    Calprotectin Other Phase PHASE4 Ulcerative Colitis ClinicalTrials.gov
    Placebo ABBV-2222 Other Phase PHASE2 Cystic Fibrosis ClinicalTrials.gov
    ABBV-2222 Other Phase PHASE2 Cystic Fibrosis ClinicalTrials.gov
    Placebo ABBV-3067 Other Phase PHASE2 Cystic Fibrosis ClinicalTrials.gov
    ABBV-3067 Other Phase PHASE2 Cystic Fibrosis ClinicalTrials.gov
    Placebo to Methotrexate Other Phase PHASE3 Rheumatoid Arthritis ClinicalTrials.gov
    Placebo to Upadacitinib Other Phase PHASE3 Rheumatoid Arthritis ClinicalTrials.gov
    Questionnaires and dry eye tests Other Preclinical Dry Eye ClinicalTrials.gov
    ABBV-903 Tablet Form 2 Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    ABBV-903 Tablet Form 1 Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Ilorasertib Other Phase PHASE2 Advanced Cancers ClinicalTrials.gov
    GEN1044 is an immunoglobulin G1 (IgG1) bispecific antibody targeting CD3 and 5T4. Other Phase PHASE1 Locally Advanced or Metastatic Solid Tumor(s) ClinicalTrials.gov
    Placebo to match OBV/PTV/r and DSV Other Phase PHASE4 Hepatitis C, Chronic ClinicalTrials.gov
    OBV/PTV/r and DSV Other Phase PHASE4 Hepatitis C, Chronic ClinicalTrials.gov
    Surveys Other Approved Inflammatory Bowel Diseases ClinicalTrials.gov
    Health Coaching Other Approved Inflammatory Bowel Diseases ClinicalTrials.gov
    Mivebresib Other Phase PHASE1 Myelofibrosis (MF) ClinicalTrials.gov
    Enzalutamide Other Phase PHASE1 Castration Levels of Testosterone ClinicalTrials.gov
    Placebo for ABBV-903 Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Percutaneous endoscopic gastrostomy with a jejunal (PEG-J) tube Other Phase PHASE3 Advanced Parkinson's Disease ClinicalTrials.gov
    Nasojejunal (NJ) tube Other Phase PHASE3 Advanced Parkinson's Disease ClinicalTrials.gov
    Optimized Medical Treatment Drug Phase PHASE3 Advanced Parkinson's Disease ClinicalTrials.gov
    Placebo Methotrexate Other Phase PHASE3 Rheumatoid Arthritis ClinicalTrials.gov
    Placebo Upadacitinib Other Phase PHASE3 Rheumatoid Arthritis ClinicalTrials.gov
    AGN-241622 Other Phase PHASE1 Presbyopia ClinicalTrials.gov
    ABBV-011 Other Phase PHASE1 Small Cell Lung Cancer ClinicalTrials.gov
    Lopinavir/Ritonavir 400 mg/100 mg Other Phase PHASE2 COVID-19 ClinicalTrials.gov
    Placebo for ABBV-382 Other Phase PHASE1 Human Immunodeficiency Virus (HIV) ClinicalTrials.gov
    ABBV-382 Other Phase PHASE1 Human Immunodeficiency Virus (HIV) ClinicalTrials.gov
    Lutikizumab Dose B Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Lutikizumab Dose A Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Placebo to dupilumab Other Phase PHASE3 Atopic Dermatitis ClinicalTrials.gov
    Unspecific group training Other Approved Parkinson's Disease ClinicalTrials.gov
    Psycho-social CBT based training Other Approved Parkinson's Disease ClinicalTrials.gov
    Apremilast Other Phase PHASE4 Psoriasis ClinicalTrials.gov
    AGN-151607 Other Phase PHASE2 Post-Operative Atrial Fibrillation ClinicalTrials.gov
    Leuprolide Acetate (LA) Other Phase PHASE3 Central Precocious Puberty (CPP) ClinicalTrials.gov
    18F-FluorApoTrace Other Phase EARLY_PHASE1 Diffuse Large B Cell Lymphoma ClinicalTrials.gov
    RGX-314 Other Phase PHASE2 Neovascular Age-related Macular Degeneration ClinicalTrials.gov
    Moxifloxacin 400mg Other Phase PHASE1 Healthy ClinicalTrials.gov
    Placebo for ABBV-950 Other Phase PHASE1 Upper Limb Spasticity ClinicalTrials.gov
    ABBV-950 Other Phase PHASE1 Upper Limb Spasticity ClinicalTrials.gov
    Cytochrome P450 (CYP) Substrates Other Phase PHASE1 Ulcerative Colitis (UC) ClinicalTrials.gov
    ABBV-119 Other Phase PHASE2 Cystic Fibrosis (CF) ClinicalTrials.gov
    No intervention, this is an observational study Other Preclinical Acute Pancreatitis ClinicalTrials.gov
    Placebo for abatacept (0.9% Sodium Chloride Injection or Solution for Infusion) Other Phase PHASE3 Rheumatoid Arthritis (RA) ClinicalTrials.gov
    Abatacept Other Phase PHASE3 Rheumatoid Arthritis (RA) ClinicalTrials.gov
    [14C] ABBV-CLS-7262 Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Ubrogepant 100 MG [Ubrelvy] Other Phase PHASE4 Headache, Migraine ClinicalTrials.gov
    Ubrogepant 50 MG [Ubrelvy] Other Phase PHASE4 Headache, Migraine ClinicalTrials.gov
    Placebo Microcrystalline Cellulose Other Approved Adjuvant Zinc May Increase the Efficacy of Botulinum Toxin ClinicalTrials.gov
    zinc citrate 50 mg Other Approved Adjuvant Zinc May Increase the Efficacy of Botulinum Toxin ClinicalTrials.gov
    Clindamycin Other Phase PHASE3 Methicillin-Resistant Staphylococcus Aureus ClinicalTrials.gov
    Cefadroxil Other Phase PHASE3 Methicillin-Resistant Staphylococcus Aureus ClinicalTrials.gov
    Flucloxacillin Other Phase PHASE3 Methicillin-Resistant Staphylococcus Aureus ClinicalTrials.gov
    Oxacillin Other Phase PHASE3 Methicillin-Resistant Staphylococcus Aureus ClinicalTrials.gov
    Vancomycin Other Phase PHASE3 Methicillin-Resistant Staphylococcus Aureus ClinicalTrials.gov
    Sotorasib Other Phase PHASE1 Solid Tumor ClinicalTrials.gov
    Binimetinib Other Phase PHASE1 Solid Tumor ClinicalTrials.gov
    JAB-3312 Other Phase PHASE1 Solid Tumor ClinicalTrials.gov
    IMGN632 Other Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    VEGFR TKI Other Phase PHASE1 Advanced Solid Tumors Cancer ClinicalTrials.gov
    PD-1 inhibitor Other Phase PHASE1 Advanced Solid Tumors Cancer ClinicalTrials.gov
    ABBV-CLS-579 Other Phase PHASE1 Advanced Solid Tumors Cancer ClinicalTrials.gov
    GUB014295-PLACEBO Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    GUB014295 Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Prednisolone Other Phase PHASE3 Takayasu Arteritis (TAK) ClinicalTrials.gov
    Survey Administration Other Phase PHASE2 Lung Non-Small Cell Carcinoma ClinicalTrials.gov
    Biopsy Procedure Procedure Phase PHASE2 Lung Non-Small Cell Carcinoma ClinicalTrials.gov
    ethinyl estradiol/levonorgestrel Other Phase PHASE1 Hematologic Malignancies ClinicalTrials.gov
    Oxybutynin Other Phase PHASE4 Overactive Detrusor ClinicalTrials.gov
    Placebo for Albendazole Other Phase PHASE2 Onchocerciasis ClinicalTrials.gov
    Albendazole Other Phase PHASE2 Onchocerciasis ClinicalTrials.gov
    Placebo for ABBV-4083 Other Phase PHASE2 Onchocerciasis ClinicalTrials.gov
    ABBV-4083 Other Phase PHASE2 Onchocerciasis ClinicalTrials.gov
    Letrozole Other Preclinical Metastatic Breast Cancer ClinicalTrials.gov
    Palbociclib Other Preclinical Metastatic Breast Cancer ClinicalTrials.gov
    Juvéderm® VOLBELLA® with Lidocaine Other Phase PHASE4 Facial Corrections ClinicalTrials.gov
    BOTOX®/VISTABEL® Other Phase PHASE4 Facial Corrections ClinicalTrials.gov
    ABBV-154 Other Phase PHASE2 Crohn's Disease ClinicalTrials.gov
    ABBV-668 ER Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    ABBV-668 IR Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Glucocorticoid Other Phase PHASE2 Polymyalgia Rheumatica ClinicalTrials.gov
    Ibrutinib 420 mg Other Phase PHASE1 Breast Neoplasms ClinicalTrials.gov
    Ibrutinib 840 mg Other Phase PHASE1 Breast Neoplasms ClinicalTrials.gov
    Ibrutinib 560 mg Other Phase PHASE1 Breast Neoplasms ClinicalTrials.gov
    Androgen suppression plus radiation therapy Drug Phase PHASE2 Adenocarcinoma of the Prostate ClinicalTrials.gov
    Placebo for E2/NETA Other Phase PHASE3 Endometriosis ClinicalTrials.gov
    modified FOLFIRINOX Other Phase PHASE1 Pancreatic Cancer ClinicalTrials.gov
    Budiglimab Other Phase PHASE1 Pancreatic Cancer ClinicalTrials.gov
    Placebo for ABBV-141 Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    ABBV-141 Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Bimatoprost Sustained Release Implant Other Preclinical Open-angle Glaucoma ClinicalTrials.gov
    Upadacitinib (ABT-494) Other Phase PHASE1 Atopic Dermatitis ClinicalTrials.gov
    HAC 20L Other Phase PHASE2 Nasolabial Folds ClinicalTrials.gov
    Celecoxib Other Phase PHASE1 Myeloproliferative Neoplasm ClinicalTrials.gov
    Drug: Placebo for ABBV-1088 Drug Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Drug: ABBV-1088 Drug Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Veliparib Placebo Other Phase PHASE3 Metastatic Breast Cancer ClinicalTrials.gov
    Lab work Other Phase EARLY_PHASE1 Infertility ClinicalTrials.gov
    Leuprolide Acetate 3.75 MG/ML Other Phase EARLY_PHASE1 Infertility ClinicalTrials.gov
    Elagolix 200 MG Other Phase EARLY_PHASE1 Infertility ClinicalTrials.gov
    Glecaprevir and Pibrentasvir Other Phase PHASE4 Hepatitis C ClinicalTrials.gov
    HCV education from a health care provider Other Phase PHASE4 Hepatitis C ClinicalTrials.gov
    Cepheid POC HCV Viremia (RNA) test Other Phase PHASE4 Hepatitis C ClinicalTrials.gov
    ABBV-787 Other Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Cyclin D1 gene (CCDN1) /immunoglobulin heavy chain (IGH) fluorescence in situ hybridization (FISH) assay Other Phase PHASE1 AL Amyloidosis ClinicalTrials.gov
    No Interventions Other Preclinical Interstitial Lung Disease ClinicalTrials.gov
    Darigabat Other Phase PHASE2 Panic Disorder ClinicalTrials.gov
    Tavapadon Other Phase PHASE3 Parkinson Disease ClinicalTrials.gov
    Glecaprevir/Pibrentasvir (GLE/PIB) Other Phase PHASE3 Hepatitis C Virus (HCV) ClinicalTrials.gov
    Telehealth in Parole/Probation Office Other Approved Hepatitis C ClinicalTrials.gov
    Siltuximab Other Phase PHASE1 Non-Hodgkin Lymphoma ClinicalTrials.gov
    Eftozanermin alfa Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Lifitegrast 5% Ophthalmic Solution Other Phase PHASE1 Dry Eye Disease ClinicalTrials.gov
    AGN-231868 Vehicle Other Phase PHASE1 Dry Eye Disease ClinicalTrials.gov
    AGN-242428 Vehicle Other Phase PHASE1 Dry Eye Disease ClinicalTrials.gov
    AGN-231868 Other Phase PHASE1 Dry Eye Disease ClinicalTrials.gov
    AGN-242428 Other Phase PHASE1 Dry Eye Disease ClinicalTrials.gov
    CVL-865 Other Phase PHASE2 Seizures ClinicalTrials.gov
    Programmed Cell Death-1 (PD-1) Inhibitor Other Phase PHASE1 Advanced Solid Tumor Cancer ClinicalTrials.gov
    Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor (TKI) Other Phase PHASE1 Advanced Solid Tumor Cancer ClinicalTrials.gov
    ABBV-CLS-484 Other Phase PHASE1 Advanced Solid Tumor Cancer ClinicalTrials.gov
    Epcoritamab, lenalidomide and rituximab Other Phase PHASE2 Relapsed/Refractory Large B-cell Lymphoma ClinicalTrials.gov
    GA101 Other Phase PHASE2 Chronic Lymphocytic Leucemia ClinicalTrials.gov
    Sanacoach Parkinson (SCP) Other Approved Parkinson Disease ClinicalTrials.gov
    No intervention. Other Preclinical Neovascular Age-Related Macular Degeneration (nAMD) ClinicalTrials.gov
    Upadacitinib Oral Product Other Phase PHASE3 Colitis, Ulcerative ClinicalTrials.gov
    ABBV-637 Other Phase PHASE1 Advanced Solid Tumors Cancer ClinicalTrials.gov
    Next Generation Emulsion Preservative Free Eye Drops (NGE-UD) Other Preclinical Dry Eye ClinicalTrials.gov
    Placebo for CVC 300 mg Other Phase PHASE2 HIV-1-infection ClinicalTrials.gov
    Placebo for CVC 150 mg Other Phase PHASE2 HIV-1-infection ClinicalTrials.gov
    CVC 300 mg Other Phase PHASE2 HIV-1-infection ClinicalTrials.gov
    CVC 150 mg Other Phase PHASE2 HIV-1-infection ClinicalTrials.gov
    ALIA-1758 Other Phase PHASE1 Alzheimer Disease ClinicalTrials.gov
    100mg Eluxadoline Other Phase PHASE3 Irritable Bowel Syndrome ClinicalTrials.gov
    25mg Eluxadoline Other Phase PHASE3 Irritable Bowel Syndrome ClinicalTrials.gov
    Comparator Other Preclinical Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for Which Risankizumab is an FDA-approved Treatment ClinicalTrials.gov
    Estradiol /norethindrone acetate (E2/NETA) Other Phase PHASE3 Heavy Menstrual Bleeding ClinicalTrials.gov
    CVL-231 30 mg Other Phase PHASE2 Schizophrenia ClinicalTrials.gov
    Fosigotifator Other Phase PHASE1 ALS ClinicalTrials.gov
    Donor Lymphocyte Infusion Other Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Mesalamine Other Phase PHASE3 Ulcerative Colitis (UC) ClinicalTrials.gov
    Restylane® Perlane® Lidocaine Other Phase PHASE3 Mid Face Volume Deficit ClinicalTrials.gov
    Sorafenib Other Phase PHASE2 Hepatocellular Carcinoma ClinicalTrials.gov
    Lenvatinib Other Phase PHASE2 Hepatocellular Carcinoma ClinicalTrials.gov
    Tremelimumab Other Phase PHASE2 Hepatocellular Carcinoma ClinicalTrials.gov
    Durvalumab Other Phase PHASE2 Hepatocellular Carcinoma ClinicalTrials.gov
    Biopsy Other Phase PHASE1 Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder ClinicalTrials.gov
    Optive MEGA-3 (OM3) Other Preclinical Dry Eye ClinicalTrials.gov
    Fluorescence Imaging Other Phase PHASE2 IBD ClinicalTrials.gov
    Adalimumab-800CW Other Phase PHASE2 IBD ClinicalTrials.gov
    Bimatoprost (SR) Other Phase PHASE3 Open-Angle Glaucoma ClinicalTrials.gov
    Lumbar Puncture Other Phase PHASE2 Acute Monocytic Leukemia ClinicalTrials.gov
    Cladribine Other Phase PHASE2 Acute Monocytic Leukemia ClinicalTrials.gov
    Emraclidine 10 mg Other Phase PHASE2 Schizophrenia ClinicalTrials.gov
    Erwinia asparaginase Other Phase PHASE1 Refractory Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Pegaspargase Other Phase PHASE1 Refractory Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Intrathecal Triples Other Phase PHASE1 Refractory Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Blinatumomab Other Phase PHASE1 Refractory Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Placebo to Adalimumab Other Phase PHASE3 Psoriatic Arthritis ClinicalTrials.gov
    MedicWise Other Approved Crohn Disease ClinicalTrials.gov
    Placebo for ABBV-552 Other Phase PHASE2 Alzheimer's Disease (AD) ClinicalTrials.gov
    Recombinant Granulocyte Colony-Stimulating Factor Other Phase PHASE1 Acute Biphenotypic Leukemia ClinicalTrials.gov
    Mitoxantrone Other Phase PHASE1 Acute Biphenotypic Leukemia ClinicalTrials.gov
    ABBV-303 Other Phase PHASE1 Solid Tumors ClinicalTrials.gov
    Cariprazine Flexible Dose Other Phase PHASE3 Schizophrenia ClinicalTrials.gov
    Emraclidine 15 mg Other Phase PHASE2 Schizophrenia ClinicalTrials.gov
    Placebo for Budigalimab Other Phase PHASE2 Human Immuno-deficiency Virus (HIV) Disease ClinicalTrials.gov
    ABBV-1042 Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Placebo for ABBV-1088 Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    ABBV-1088 Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Acalabrutinib Other Phase PHASE3 Chronic Lymphocytic Leukemia ClinicalTrials.gov
    Chlorambucil Other Phase PHASE3 Lymphocytic Leukemia, Chronic ClinicalTrials.gov
    XEN45 Glaucoma Treatment System Drug Phase PHASE4 Open-angle Glaucoma ClinicalTrials.gov
    Saline Control Other Phase PHASE3 Acne Scars ClinicalTrials.gov
    Venetoclax combined with Orelabrutinib Other Phase PHASE2 Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) ClinicalTrials.gov
    Venetoclax combined with Acalabrutinib Other Phase PHASE2 Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) ClinicalTrials.gov
    Venetoclax combined with Zanubrutinib Other Phase PHASE2 Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) ClinicalTrials.gov
    Venetoclax combined with Ibrutinib Other Phase PHASE2 Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) ClinicalTrials.gov
    venetoclax and ibrutinib (I+VEN) Other Phase PHASE2 Intermediate Risk Chronic Lymphocytic Leukemia ClinicalTrials.gov
    DRC Other Phase PHASE2 Waldenstrom Macroglobulinemia ClinicalTrials.gov
    Venetoclax; Rituximab Other Phase PHASE2 Waldenstrom Macroglobulinemia ClinicalTrials.gov
    JUVÉDERM® VOLITE™ Other Phase PHASE3 Perioral Lines ClinicalTrials.gov
    First line therapy Drug Preclinical CLL/SLL ClinicalTrials.gov
    Test and treat plus peer mentors Other Approved Hepatitis C Virus Infection, Response to Therapy of ClinicalTrials.gov
    ABBV-916 Other Phase PHASE2 Alzheimer's Disease (AD) ClinicalTrials.gov
    ABBV-155 Other Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    ABBV-668 Other Phase PHASE2 Ulcerative Colitis ClinicalTrials.gov
    HAC 22L Other Phase PHASE3 Facial Volume Deficit ClinicalTrials.gov
    ABBV-1354 Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Armour Thyroid Other Phase PHASE2 Hypothyroidism ClinicalTrials.gov
    Copanlisib Other Phase PHASE1 Diffuse Large B Cell Lymphoma ClinicalTrials.gov
    Best Available Therapy (BAT) Drug Phase PHASE3 Myelofibrosis (MF) ClinicalTrials.gov
    ABBV-243 Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    AGN-151597 Other Phase PHASE1 Advanced Retinitis Pigmentosa ClinicalTrials.gov
    Fludeoxyglucose F-18 Other Phase PHASE2 B-Cell Non-Hodgkin Lymphoma ClinicalTrials.gov
    ABBV-CLS-616 Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Inotuzumab Ozogamicin Other Phase PHASE1 B-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Oral Prednisone - Hospital Dose Steroids Other Phase PHASE4 Ulcerative Colitis Acute ClinicalTrials.gov
    Oral prednisolone Taper Other Phase PHASE4 Ulcerative Colitis Acute ClinicalTrials.gov
    Oral Upadacitinib Placebo Other Phase PHASE4 Ulcerative Colitis Acute ClinicalTrials.gov
    Intravenous Methylprednisolone Other Phase PHASE4 Ulcerative Colitis Acute ClinicalTrials.gov
    Oral Upadacitinib Other Phase PHASE4 Ulcerative Colitis Acute ClinicalTrials.gov
    Alternately treated with VA/low CHA regimen Other Phase PHASE2 Intensive Chemotherapy Unfit ClinicalTrials.gov
    ABBV-CLS-628 Other Phase PHASE2 Autosomal Dominant Polycystic Kidney Disease ClinicalTrials.gov
    TNB-383B Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Bone Marrow Aspiration and Biopsy Other Phase PHASE1 B Acute Lymphoblastic Leukemia ClinicalTrials.gov
    ABBV-525 Other Phase PHASE1 Diffuse Large B-Cell Lymphoma ClinicalTrials.gov
    Deucravacitinib Other Phase PHASE4 Moderate Plaque Psoriasis ClinicalTrials.gov
    Corticosteroid (CS) Other Phase PHASE3 Giant Cell Arteritis (GCA) ClinicalTrials.gov
    Breast Milk Sampling Other Phase PHASE4 Inflammatory Bowel Disease ClinicalTrials.gov
    XEN45 (Glaucoma Gel Stent) Other Phase PHASE3 Open-Angle Glaucoma ClinicalTrials.gov
    CC-99282 Other Phase PHASE2 Non-Hodgkin Lymphoma ClinicalTrials.gov
    Polatuzumab Vedotin Other Phase PHASE2 Non-Hodgkin Lymphoma ClinicalTrials.gov
    Doxorubicin Hydrochloride [HCl] Other Phase PHASE2 Non-Hodgkin Lymphoma ClinicalTrials.gov
    Durysta, Bimatoprost Intracameral Implant 10 µg Other Phase PHASE4 Glaucoma ClinicalTrials.gov
    CVL-871 3.0 mg Other Phase PHASE2 Apathy in Dementia ClinicalTrials.gov
    CVL-871 1.0 mg Other Phase PHASE2 Apathy in Dementia ClinicalTrials.gov
    venetoclax + azacitidine +/- donor lymphocyte infusion Other Phase PHASE1 MDS ClinicalTrials.gov
    Placebo for Navitoclax Other Phase PHASE3 Myelofibrosis (MF) ClinicalTrials.gov
    ABBV-324 Other Phase PHASE1 Hepatocellular Cancer ClinicalTrials.gov
    Intravenous (IV) Etentamig Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Subcutaneous (SC) Etentamig Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Cladribine, Cytarabine, Mitoxantrone, G-CSF (CLAG-M) regimen Other Phase PHASE2 Relapsed or Refractory Acute Myeloid Leukemia (AML) ClinicalTrials.gov
    Upadacitinib 15 MG [Rinvoq] Other Phase PHASE4 Psoriatic Arthritis ClinicalTrials.gov
    Investigator's Choice Chemotherapy Drug Phase PHASE3 Diffuse Large B-Cell Lymphoma ClinicalTrials.gov
    Rituximab and Lenalidomide Other Phase PHASE1 Diffuse Large B-Cell Lymphoma ClinicalTrials.gov
    rituximab, ifosfamide, carboplatin, and etoposide phosphate Other Phase PHASE1 Diffuse Large B-Cell Lymphoma ClinicalTrials.gov
    rituximab, cyclophosphamide, reduced dose of doxorubicin, vincristine, and prednisone Other Phase PHASE1 Diffuse Large B-Cell Lymphoma ClinicalTrials.gov
    gemcitabine and oxaliplatin Other Phase PHASE1 Diffuse Large B-Cell Lymphoma ClinicalTrials.gov
    rituximab, cytarabine, dexamethasone, and oxaliplatin/carboplatin Other Phase PHASE1 Diffuse Large B-Cell Lymphoma ClinicalTrials.gov
    rituximab and bendamustine Other Phase PHASE1 Diffuse Large B-Cell Lymphoma ClinicalTrials.gov
    rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone Other Phase PHASE1 Diffuse Large B-Cell Lymphoma ClinicalTrials.gov
    Epcoritamab (maintenance) Other Phase PHASE1 Diffuse Large B Cell Lymphoma ClinicalTrials.gov
    Epcoritamab (monotherapy) Drug Phase PHASE1 Diffuse Large B Cell Lymphoma ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ABBVIE INC.
    • Ticker Symbol: ABBV

Search

News categories